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ABSTRACT
The integrity and stability of DNA is essential to life since it stores genetic
information in every living cell. Chemicals from the environment will assault DNA to
form various types of DNA damage, ranging from small covalent crosslinks between
neighboring DNA bases as seen in cyclobutane pyrimidine dimers, to big bulky adducts
derived from benzo[a]pyrene. This resultant damage will lead to replication block and
mutation if remain unrepaired and will eventually cause cancer or other genetic diseases.
The work presented in this dissertation has illustrated the important role of the AlkB
family DNA repair enzymes in cancer and Wilson’s Disease. In addition, we discovered
these enzymes can modify epigenetic markers that affect DNA regulation. We also
studied sequence-dependent conformational heterogeneity of aminobiphenyl adduct on
DNA replication.
The AlkB family DNA repair enzyme is a family of α-ketoglutarate (αKG)- and
non-heme iron-dependent dioxygenases. Among all the homologs in this family, human
ALKBH2 and ALKBH3, and E. coli AlkB have been proved to be the major enzymes
that directly remove the alkyl adducts from alkylated DNA bases like 3-methylcytosine
(3mC) and 1-methyladenine (1mA). These DNA adducts will cause strong replication
block and mutagenicity in cell if AlkB enzymes are suppressed by toxicants. Cancerassociated mutations often lead to perturbed cellular energy metabolism and
accumulation

of

potentially

harmful

oncometabolites.

Chiral

molecule

2-

hydroxyglutarate (2HG) and its two stereoisomers (D- and L-2HG) have been
demonstrated to competitively inhibit several αKG- and iron-dependent dioxygenases,
including ALKBH2 and ALKBH3. In this work, we carried out detailed kinetic analyses

of DNA repair reactions catalyzed by ALKBH2, ALKBH3 and the bacterial AlkB in
the presence of D- and L-2HG in both double and single stranded DNA contexts. We
not only determined kinetic parameters of inhibition, including kcat, KM, and Ki, but also
correlated the relative concentrations of 2HG and αKG previously measured in tumor
cells with the inhibitory effect of 2HG on the AlkB family enzymes. Both D- and L2HG significantly inhibited the human DNA repair enzymes ALKBH2 and ALKBH3
under pathologically relevant concentrations (73-88% for D-2HG and 31-58% for L2HG inhibition). This work provides a new perspective that the elevation of either Dor L-2HG in cancer cells may contribute to an increased mutation rate by inhibiting the
DNA repair carried out by the AlkB family enzymes and thus exacerbate the genesis
and progression of tumors.
Another type of inhibitor of AlkB is toxic metals, such as, copper. Disturbed
metabolism of copper ions can cause diseases, such as Wilson’s disease (WD). In this
work, we investigated the inhibitory effect of Cu(II) ion on the AlkB family DNA repair
enzymes, include human ALKBH2, ALKBH3, and E. coli AlkB proteins. None of the
three proteins were significantly inhibited under normal cellular copper concentrations.
But under WD related condition, we observed the activities of all three enzymes were
strongly suppressed (inhibition from 95.2 to 100.0%).

We also noted the repair

efficiency under ds-DNA condition is less susceptible than ss-DNA to the inhibition.
AlkB can repair many alkylated DNA bases including 3mC, 1mA, 3metheylthymine, 1-methylguanine, ethenoadenine and ethenocytosine. But in this work,
we found a new DNA base substrate for AlkB, 5-Methylcytosine (5mC). 5mC in DNA
CpG islands is an important epigenetic biomarker for mammalian gene regulation. It is

oxidized to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5carboxylcytosine (5caC) by the ten-eleven translocation (TET) family enzymes, which
are also α-KG/Fe(II)-dependent dioxygenases. In this work, we demonstrate that the
epigenetic marker 5mC is biochemically modified to 5hmC, 5fC, and 5caC by
ALKBH2, ALKBH3, and AlkB. Theoretical calculations indicate that these enzymes
may bind 5mC in the syn-conformation, placing the methyl group comparable to 3methylcytosine, the prototypic substrate of AlkB. This is the first demonstration of the
AlkB proteins to oxidize a methyl group attached to carbon, instead of nitrogen, on a
DNA base. These observations suggest a broader role in epigenetics for these DNA
repair proteins.
Besides alkyl DNA adducts, there are bulky DNA adducts existing in human. Bulky
organic carcinogens are activated in vivo and subsequently react with nucleobases of
cellular DNA to produce adducts. Some of these DNA adducts exist in multiple
conformations that are slowly interconverted to one another. Different conformations
could contribute to different mutagenic and repair outcomes. Unfortunately, studies on
the conformation-specific inhibition of replication, which is more relevant to cell
survival, are scarce; this is presumably due to difficulties in studying the structural
dynamics of DNA lesions at the replication fork. It is challenging to capture the exact
nature of replication inhibition by traditional end-point assays, since they usually detect
either the ensemble of consequences of all the conformers or the culmination of all
cellular behaviors, such as mutagenicity or survival rate. One article reported an unusual
sequence-dependent conformational heterogeneity involving FABP-modified (4′fluoro-4-aminobiphenyl) DNA under different sequence contexts. There were 67% B-

type (B) conformation and 33% stacked (S) conformation in TG1*G2T sequence;
whereas, 100% B conformation was observed in TG1G2*T sequence. In this study, we
applied primer extension assay to compare the inhibition models between these two
FABP-modified DNA sequences. We utilized a combination of surface plasmon
resonance (SPR) and HPLC-based steady-state kinetics to reveal the differences in
terms of binding affinity and inhibition with polymerase between these two conformers
(67%B:33%S and 100%B). The conformational heterogeneities from these two
sequences lead to different types of inhibition on replication.
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ABSTRACT
Cancer-associated mutations often lead to perturbed cellular energy metabolism and
accumulation of potentially harmful oncometabolites.

One example is the chiral

molecule 2-hydroxyglutarate (2HG); its two stereoisomers (D- and L-2HG) have been
found with abnormally high concentrations in tumors featuring anomalous metabolic
pathways. 2HG has been demonstrated to competitively inhibit several α-ketoglutarate
(αKG)- and non-heme iron-dependent dioxygenases, including some of the AlkB family
DNA repair enzymes, such as ALKBH2 and ALKBH3. However, previous studies have
only provided the IC50 values of D-2HG on the enzymes and the results have not been
correlated to physiologically relevant concentrations of 2HG and αKG in cancer cells.
In this work, we carried out detailed kinetic analyses of DNA repair reactions catalyzed
by ALKBH2, ALKBH3 and the bacterial AlkB in the presence of D- and L-2HG in both
double and single stranded DNA contexts. We determined kinetic parameters of
inhibition, including kcat, KM, and Ki. We also correlated the relative concentrations of
2HG and αKG previously measured in tumor cells with the inhibitory effect of 2HG on
the AlkB family enzymes. Both D- and L-2HG significantly inhibited the human DNA
repair enzymes ALKBH2 and ALKBH3 under pathologically relevant concentrations
(73-88% for D-2HG and 31-58% for L-2HG inhibition). This work provides a new
perspective that the elevation of either D- or L-2HG in cancer cells may contribute to
an increased mutation rate by inhibiting the DNA repair carried out by the AlkB family
enzymes and thus exacerbate the genesis and progression of tumors.
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KEYWORDS. 2-hydroxyglutarate, oncometabolite, ALKBH2, ALKBH3, AlkB, DNA
repair inhibition, tumorigenesis
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INTRODUCTION
Mutations in the isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) are frequently
found in >75% human low grade glioma, secondary glioblastoma, cartilaginous tumor
and >20% of acute myeloid leukemia.1–5 Tumor-derived mutant forms of IDH catalyze
the

NAD-dependent

dehydrogenation

of

α-ketoglutarate

(αKG)

to

D-2-

hydroxyglutarate (D-2HG), a function that supplants the physiological activity of IDH,
which entails reductive decarboxylation of isocitrate to αKG (Figure 1b).6–13 L-2HG,
the stereoisomer of D-2HG, has been identified as an oncometabolite with elevated
concentrations in renal cell carcinoma9,10 neurodegenerative disorders,14,15 and in tissues
under oxygen limitation or hypoxic conditions.11,12 The elevation of L-2HG under such
conditions is key from either loss of expression of L-2HG dehydrogenase or
promiscuous substrate utilization by lactate dehydrogenase A and malate
dehydrogenases 1 and 2.10,12 Both D-2HG (R-2HG) and L-2HG (S-2HG) and several
other molecules have been identified as oncometabolites because their accumulations in
different tumor cells are originated from dysregulated energy metabolism pathways and
metabolic imbalance.16–20 Because of their structural similarity to αKG, both D- and L2HG could compete with αKG and inhibit enzymatic processes that use αKG as a
substrate. One important class of enzymes that utilizes αKG—and thus potentially
susceptible to inhibition by 2HG—is the non-heme iron- and αKG-dependent
dioxygenases, a family of enzymes with over 80 different members.21–24 2HG has been
demonstrated to inhibit several αKG-dependent enzymes, such as histone demethylases,
prolyl hydroxylases, the TET family 5-methlycytosine (5mC) hydroxylases,7 and some
of the AlkB family DNA repair enzymes, such as ALKBH2 and ALKBH3.8,25 However,
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in the case of the AlkB proteins, previous in vitro studies have only provided the IC50
values of 2HG on the enzymes and the results have not been extrapolated to
physiologically relevant concentrations of 2HG and αKG in cancer cells. While Wang
et al. demonstrated that the accumulation of DNA damage in cells producing high levels
of D-2HG is consistent with inhibition of ALKBH2 and/or ALKBH3,25 the detailed
mechanism of inhibition of the AlkB enzymes by 2HG has not been reported. A careful
study of the inhibitory effect of both D- and L-2HG on AlkB repair enzymes is needed
to quantify the extent of inhibition of the direct reversal DNA repair pathways;
perturbations in these pathways would lead to unrepaired mutagenic DNA lesions,
which would cause mutations that can accelerate tumor progression or enable metastatic
growth. Such a study would also facilitate the identification of druggable targets related
to the AlkB enzymes because many alkylating chemotherapeutic agents generate DNA
adducts that are repaired by this family of repair enzymes.26 Inhibition of these enzymes
would thus afford a clinical benefit in anti-tumor regimens.
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Figure 1. a) Repair mechanism of the AlkB family enzymes on alkyl DNA lesions.
Adduct m1A is used here as an example to show the steps of enzymatic catalysis. b)
The generation of D- and L-2HG and mechanisms of inhibition to the AlkB family DNA
repair enzymes.

The Escherichia coli AlkB protein was discovered to be an αKG/Fe(II)-dependent
dioxygenase that oxidizes the alkyl groups in DNA adducts formed by alkylation agents,
ultimately restoring the undamaged DNA bases (Figure 1a).27–29 Nine human homologs
of AlkB have been identified as ALKBH1-8 and FTO.29,30 Among these homologs,
ALKBH231–36 and ALKBH337–40 have been identified as major DNA repair enzymes
for repairing small alkyl DNA lesions. Since the initial discovery of the catalytic
8

mechanism of AlkB in 2002,27,28 a range of alkyl adducts have been identified as
substrates for AlkB, ALKBH2 and ALKBH3, both in vitro and in vivo.24 The adducts
include all of the seven N-methyl adducts occurring at the Watson-Crick (W-C) basepairing face of the four nucleobases.41 The seven adducts include 3-methylcytosine
(m3C),

N4-methylcytosine,

1-methyladenine

(m1A),

N6-methyladenine,

3-

methylthymine, 1-methylguanine, and N2-methylguanine. AlkB has also been reported
to repair other DNA adducts, such as 1,N6-ethenoadenine, 1,N6-ethanoadenine, 3,N4ethenocytosine, 3-ethylcytosine, 1,N2-ethenoguanine, 3,N4-α-hydroxyethanocytosine,
3,N4-α-hydroxypropanocytosine,
methylguanine,

N2-ethylguanine,

N2-furan-2-yl-methylguanine,

N2-tetrahydrofuran-2-yl-

malondialdehydeguanine,

α-

hydroxypropanoguanine, and γ-hydroxypropanoguanine.41–49 The repair efficiency and
substrate scope of the AlkB family enzymes have been recently reviewed in
detail.24,30,50–54
In this work, we carried out kinetic analyses of DNA repair reactions catalyzed by
ALKBH2, ALKBH3 and AlkB in the presence of the inhibitors D- and L-2HG.
Oligonucleotides containing the methylated bases m1A and m3C were selected as
substrates for the repair reactions because they are most efficiently repaired by these
three enzymes.24 For each substrate/enzyme/inhibitor combination, we determined a
complete panel of kinetic parameters, (kcat, KM, kcat/KM, Ki), and correlated the relative
concentrations of 2HG and αKG found in tumor cells with the inhibitory effect of 2HG
on the AlkB family enzymes. Because ALKBH2 preferentially repairs adducts in
double stranded (ds) DNA and ALKBH3 prefers to repair lesions in a single stranded
(ss) DNA context, we tested the three repair enzymes with both ds and ss DNA
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substrates. This is the first report of 2HG inhibition of AlkB family DNA repair
evaluated in both single- and double- stranded DNA. We also developed an HPLCbased method to study DNA repair in the ds-DNA. The results showed that both
ALKBH2 and ALKBH3, the major mammalian direct reversal repair enzymes for
alkylated DNA damage, were significantly inhibited by D- and L-2HG under
pathophysiologically relevant conditions.
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EXPERIMENTAL PROCEDURES
Oligonucleotide Synthesis. Sixteen-mer oligonucleotides were synthesized with the
sequence 5’-GAAGACCTXGGCGTCC-3’ containing the lesions m1A and m3C at the
X position.43,55 The complementary 23mer oligonucleotides were synthesized with the
sequence of 5′-CTGGGACGCCYAGGTCTTCACTG-3′, where Y represents the
position incorporating the regular bases T or G, and named as 23mer-Tcp or 23mer-Gcp.
The 23mer oligonucleotides complementary to 23mer-Tcp and 23mer-Gcp were also
synthesized, with the sequence 5′-CAGTGAAGACCTZGGCGTCCCAG-3′, where Z
was the regular base A or C, named as 23mer-A or 23mer-C. All DNA syntheses
employed solid-phase phosphoramidite chemistry performed on a MerMade-4
Oligonucleotide Synthesizer.55 The oligonucleotides were purified by HPLC (Thermo
Fisher Scientific) on a DNAPac PA-100 Semi-Preparative column (Phenomenex).
Solvent A was 100 mM 1:1 triethylamine-acetic acid (TEAA) in water and solvent B
was 100% acetonitrile. The concentration of DNA was determined by UV absorbance
at 260nm by NanoDrop.

The oligonucleotides were characterized by HPLC-

electrospray ionization triple quadrupole time of flight mass spectrometry (AB Sciex)
(Table S1).
Expression and Purification of the AlkB, ALKBH2 and ALKBH3 Proteins.
ALKBH2, ALKBH3 and AlkB were expressed and purified as described and shown
previously.47,55 In the following section, AlkB is used as an example to illustrate the
purification protocols.

Briefly, His-tagged AlkB was obtained by transforming

pET28a-AlkB into E. coli Rosetta2(DE3)pLysS or BL21(DE3)pLysS cells and protein
expression was induced by the addition of 1mM isopropyl-b-D-thiogalactopyranoside
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(IPTG) at 37 ℃ (37 ℃ for ALKBH2 and 30 ℃ for ALKBH3). The expressed protein
was purified by affinity chromatography.

Thrombin was used to digest His-tag

containing AlkB protein. The final purified protein was stored -80 °C in AlkB storage
buffer as previously described.55
Enzymatic Reaction. To assay the AlkB family demethylase activity toward the two
substrates in ss- and ds-DNA, the enzymatic reactions were performed at 37 °C at
different time points for the kinetic study of the AlkB reaction in buffer [70.0 μM
Fe(NH4)2(SO4)2·6H2O, 0.93 mM αKG (0.1 mM for 2-HG inhibition assay), 1.86 mM
ascorbic acid and 46.5 mM HEPES (pH 8.0)]. The reactions were stopped by adding
10 mM EDTA followed by heating at 95 °C for 5 min. Typically, the purified proteins
were incubated with oligonucleotides containing DNA adducts in the presence of all
cofactors in a 20 μL reaction volume. In order to separate substrate and product, 16mer
m1A and A or 16mer m3C and C, the HPLC condition started with a 5 min gradient of
1.5 M ammonium acetate from 50% to 65%, followed by 2 min 70% ammonium acetate.
The column was DNApac PA-100 (4× 250 mm) (Thermo Scientific). The UV detection
wavelength was at 260 nm. Each reaction was carried out in triplicate.
For the double-stranded DNA substrates, 1.5 equivalents of the 23mer complementary
oligonucleotides, 23mer-Tcp or 23mer-Gcp, were annealed with 16mer oligos by
heating the mixture at 80 °C for 10 min and then cooling down to room temperature
with the rate of 1 °C/10 s. The post-reaction treatments were similar to those for the ssDNA reactions, except 1.75 equivalents of 23mer-A and 23mer-C were added together
with 10 mM EDTA followed by heating up to 95 °C for 10 min and then cooled down
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to room temperature with the same rate as used for annealing. The quantification
method was the same as described above. Each reaction was carried out in triplicate.
Kinetic Studies. To determine KM, kcat and Ki values for the repair reactions, initial
rates were obtained by keeping the DNA substrate and enzyme concentration constant
and varying αKG concentration with or without various concentrations of D- or L-2HG
(0, 1.0, 3.0, 5.0, 7.0, 9.0, 37.3 mM). All reactions were performed at 37 °C in triplicate
and the data were analyzed by GraphPad Prism 5 with the Michaelis-Menten kinetics
model.

The

inhibition

curves

1/V0=1/Vmax+(KM/Vmax)×(1+[I]/Ki)×(1/[S]).
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were

fit

to

the

equation:

RESULTS
To test the inhibitory effect of D- and L-2HG on the AlkB family enzymes, we first
chemically synthesized oligonucleotides by site-specifically incorporating m1A and
m3C, the major substrates of the AlkB family enzymes.24,43 We also expressed and
purified recombinant human ALKBH2 and ALKBH3 proteins, and the E. coli AlkB
protein.55 Then, we performed kinetic experiments to determine the kcat and KM of the
three enzymes as they repair the two adducts in both ds- and ss-DNA. After that, we
measured the Ki of D- and L-2HG on the repair reactions, and finally evaluated the
inhibitory effect of the oncometabolites in the concentration range reported to occur in
certain human cancers.
Oligonucleotide Synthesis and Protein Purification. Two 16mer oligonucleotides
containing m1A and m3C were chemically synthesized with the sequence 5’GAAGACCTXGGCGTCC-3’ (X denotes the alkylated base).43

After HPLC

purification, the identity of the oligonucleotides was confirmed by comparing the
theoretical m/z of the oligonucleotides with the observed m/z from high resolution LCMS (Table S1). The genes for E. coli AlkB and its human homologs ALKBH2 and
ALKBH3 were cloned into pET28a+ expression vector; the incorporation of the correct
sequences was confirmed by sequencing the corresponding plasmids.

The three

proteins were then expressed in E. coli hosts, isolated and purified by affinity
chromatography as described in Experimental Section.55
Enzymatic Assay for Measuring Kinetic Constants. For each enzymatic reaction,
the adduct-containing oligonucleotide was incubated with the necessary cofactors for
the AlkB reaction: Fe(II), αKG, and ascorbic acid (see Experimental Section) in either
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ss- or ds-DNA. Below, m1A will be used as an example to explain the HPLC analyses.
For the ss-DNA reactions, the starting material 16mer m1A (1.5 min in Figure 2a) and
product 16mer A (2.8 min in Figure 2b) were well separated by anion exchange HPLC,
and the amount of each was quantified by reference to standard curves. For ds-DNA
repair reactions, we initially used a 16mer complementary oligonucleotide. However,
the dsDNA of starting material (16mer complementary plus 16mer m1A) and the
dsDNA of product (16mer complementary plus 16mer A) could not be fully separated
under various HPLC conditions, thus making the quantification of reactions challenging.
Therefore, we adopted a longer complementary oligonucleotide (23mer Tcp, 5.6 min in
Figure 2c), which provided a similar repair efficiency as the 16mer complementary
oligonucleotide. In the analysis of the 23mer reaction, the dsDNA of starting material
(23mer Tcp plus16mer m1A, 7.5min in Figure 2c) and the dsDNA of product (23mer
Tcp plus 16mer A, 7.7min in Figure 2c) still could not be fully separated under the
HPLC condition. Consequently, we designed another 23mer oligonucleotide that was
fully complementary to 23mer Tcp (23mer A, 5.5min in Figure 2d). After the dsDNA
reaction with 23mer Tcp, 23mer A was added to the reaction mixture, and the mixture
was heated to 80 °C for 10 min and then slowly cooled down to room temperature. The
addition of 23mer A allowed the 23mer Tcp formed perfect dsDNA with 23mer A (9.1
min in Figure 2d), thus releasing 16mer m1A and 16mer A from their previous
complementarity with 23mer Tcp. Under these conditions, the 16mer m1A and 16mer
A in the dsDNA repair reaction were well separated and quantified by the HPLC
analyses (Figure 2d). A similar analytical strategy was successfully applied to m3C
dsDNA repair reactions.
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Figure 2. HPLC analyses of the DNA repair reactions. a) Starting material 16mer
oligonucleotide containing m1A at the lesion site in ss-DNA reaction. b) ss-Product
16mer oligonucleotide containing A at the “lesion site” in the ss-DNA reaction. c) dsDNA reaction products of 16mer m1A with 23mer Tcp. The mixture containing ss16mer m1A, ss-16mer A, ds-16mer m1A:23mer Tcp, and ds-16mer A:23mer Tcp. The
latter two species were not fully separable by HPLC. d) ds-DNA reaction products of
16mer m1A with 23mer Tcp and additional 23mer A, which is fully complementary to
23mer Tcp. The duplex of 23mer Tcp:23mer A was eluted as ds-DNA, thus releasing
ss-16mer m1A and ss-16mer A for quantification.

Kinetic Analyses. After setting up a reliable procedure to quantify the conversion of
the repair reactions, we carried out systematic kinetic analyses of the AlkB family
enzymes repairing m1A and m3C. Because the purpose of this work was to measure
the possible inhibition of D- and L-2HG on the repair reactions catalyzed by αKGdependent AlkB family enzymes, the kinetic parameters of αKG in the repair reactions
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were first measured. In a typical kinetic analysis (e.g., ALKBH2 repairing m1A), 5 µM
of oligonucleotide substrate, and 0.2 µM ALKBH2 enzyme were mixed with different
concentrations of αKG (5.0-70.0 µM) and the extent of the repair reaction was
quantified at different time points (see Experimental section for details). Because the
repair of one molecule m1A to A requires the conversion of one molecule of αKG to
succinate (Figure 1), the concentrations of the product 16mer A were used to calculate
the kcat and KM of αKG. To ensure that the kinetic parameters reflect initial velocity,
the DNA and enzyme concentrations were optimized to make sure the conversion of the
repair reactions was less than 20%. All reactions were carried out in triplicate.
For ALKBH2 repair of m1A in ds-DNA (Table 1, Table S2, and Figure S1), the kcat of
αKG was 2.5 ± 0.1 min-1 and the KM was 7.3 ± 0.9 µM, which are comparable to the
literature reported kinetics parameters of other αKG dependent enzymes.7,25,56–61 The
kcat/KM value of ds-repair reaction (0.34 min-1·µM-1) shows that the repair was more
efficient than in ss-DNA (0.28 min-1·µM-1), which agrees with the literature on the
reported strand preference of ALKBH2.59 The kinetic data of ALKBH2 repair of m3C
showed a similar trend (Table 1, Table S2, Table S4 and Figure S2). In contrast to
ALKBH2’s preference for ds-DNA substrates, the kinetic parameters of ALKBH3
repair of ds-DNA substrates could not be measured due to the low conversion ratio even
with very high enzyme loading, such as 5.0 µM of ALKBH3 to 5.0 µM substrate.
Conversely, ALKBH3 could efficiently repair both DNA adducts in ss-DNA (Table 1).
These results confirm the previously reported preference of ALKBH3’s repair of ssDNA substrates.48,55 The kinetic factors of the E. coli AlkB protein were also measured
and the kcat and KM values agreed well with the literature reported kcat and KM of the
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reactions (Table 1, Table S2 and S3, and Figure S3 and S4).59,60 The kcat/KM values of
AlkB repair confirm that the enzyme prefers to repair m1A and m3C in ss-DNA as
compared with ds-DNA.55

Table 1. Kinetic constants of αKG as a substrate on ALKBH2, ALKBH3 and AlkB
repair reactions.
Enzyme

Condition

KM [µM]

kcat [min-1]

kcat/KM
[min-1·µM-1]

ss-m1A

4.1 ± 0.9

1.1 ± 0.1

0.28

ds-m1A

7.3 ± 0.9

2.5 ± 0.1

0.34

ss-m3C

1.4 ± 0.2

1.7 ± 0.1

1.20

ds-m3C

1.9 ± 0.4

2.6 ± 0.1

1.34

ss-m1A

2.3 ± 0.1

1.2 ± 0.0

0.51

ss-m3C

1.9 ± 0.4

1.7 ± 0.0

0.87

ss-m1A

7.1 ± 1.1

4.2 ± 0.2

0.59

ds-m1A

12.7 ± 1.3

4.8 ± 0.2

0.38

ss-m3C

19.9 ± 1.3

24.5 ± 0.7

1.23

ds-m3C

10.8 ± 1.9

8.2 ± 0.4

0.76

ALKBH2

ALKBH3

AlkB

2HG Inhibition of the DNA Repair Reactions Catalyzed by the AlkB Family
Enzymes. With reliable kcat and KM parameters of the three enzymes, we set out to
measure the Ki values of D-2HG and L-2HG together with a positive control, Noxalylglycine (N-OG), a commonly used inhibitor of αKG dependent enzymes.7
Because D-2HG and L-2HG are chiral molecules, polarimetry (P-2000 Digital
Polarimeter, JASCO Inc.) was utilized to measure their optical activity in a 1 decimeter
cell. The optical rotation of D-2HG was +9.5° (c = 1.0, 0.1M NaOH), which agreed
18

well to the value provided by the commercial source ([α]/D +8.5±1.5°, c = 1.0 in NaOH,
Sigma-Aldrich Co LLC.). Similarly, the optical rotation of L-2HG was -8.0°, which
was consistent with the reported -8.5±1.5° value. These values confirm the chirality
and purity of the two enantiomers.
For the inhibition of the ALKBH2 repair reaction on m1A in ds- and ss-DNA, the Ki
values for D-2HG are 280 ± 61 μM and 405 ± 61 μM, respectively (Table 2, Figure 3a
and 3b, Table S5). These data indicate that D-2HG has a stronger binding affinity for
the complex of ALKBH2 with ds-DNA than ss-DNA. For L-2HG reactions, the Ki
values are similar but smaller (stronger inhibition) than with the corresponding D-2HG
reactions (Table 2, Figure 3d and 3e, Table S5). The Ki values of N-OG show much
stronger inhibition (with about 10 times more potency, Table 2) of all repair reactions
with the Ki values ranging from 6 to 40 μM. For the inhibition of ALKBH3, a similar
trend was observed for each individual reaction for the Ki values: D-2HG > L-2HG >
N-OG (Table 2). For the inhibition of AlkB-catalyzed reactions, there is no clear trend
in the inhibitory potency between the D- and L-2HG; N-OG, however, is a stronger
inhibitor than either of 2HG isomers. We also measured the IC50 of D- and L-2HG on
the three enzymes (Table S7); in general, the IC50 values correlate well with the Ki
values.
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Table 2: Inhibition constant (Ki) of D-2HG, L-2HG and N-OG.

The individual

inhibition reactions were depicted in Figure S6 to S15.
Ki [μM]
Enzyme

Condition
D-2HG

L-2HG

N-OG

ss-m1A

405 ± 61

275 ± 41

30 ± 7

ds-m1A

280 ± 61

180 ± 36

16 ± 5

ss-m3C

152 ± 13

64 ± 3

40 ± 7

ds-m3C

79 ± 11

76 ± 11

7±2

ss-m1A

545 ± 77

185 ± 23

27 ± 4

ss-m3C

490 ± 46

228 ± 16

37 ± 3

ss-m1A

571 ± 166

337 ± 99

0.4 ± 0.1

ds-m1A

529 ± 126

598 ± 173

2.0 ± 1.3

ss-m3C

447 ± 113

276 ± 111

0.4 ± 0.1

ds-m3C

230 ± 55

308 ± 108

0.2 ± 0.0

ALKBH2

ALKBH3

AlkB
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Figure 3. Inhibition of ALKBH2 repair of m1A in ss- and ds-DNA by D- and L-2HG.
a) Inhibition of D-2HG on m1A repair in ss-DNA. b) Inhibition of D-2HG on m1A
repair in ds-DNA. c) Inhibition of D-2HG on m1A repair under D-2HG:αKG = 373:1
ratio conditions. d) Inhibition of L-2HG on m1A repair in ss-DNA. e) Inhibition of L2HG on m1A repair in ds-DNA. f) Inhibition of L-2HG on m1A repair under L2HG:αKG = 28:1 ratio conditions.

To make our experiments more relevant with regard to the anticipated cellular
concentrations of metabolites/oncometabolites observed in human tumors, we also
21

evaluated the extent inhibition of the ALKBH2 and ALKBH3 repair reactions by
varying the ratios of D- or L-2HG to αKG. For D-2HG inhibition, we tested a ratio of
concentrations for D-2HG:αKG = 373:1, which was observed in glioma patients with
IDH mutations (detailed information see the Discussion section).6 The concentration of
αKG was fixed at 100 µM to make sure that the kinetic analyses reflected steady state
catalysis (Figure S5). We found that the repair efficiencies of ALKBH2 and ALKBH3
were 73-88% inhibited under such conditions, (Figure 3c, Table 3). For L-2HG
inhibition, we tested a ratio of L-2HG:αKG= 28:1, which was reported in patients with
kidney cancers (see Discussion section).10 We found 48-58% of ALKBH2 and 31-40%
of ALKBH3’s activity was inhibited under this condition. These results suggest that
the strong inhibition on DNA repair observed in the in vitro experiments may also occur
in tumor cells of cancer patients.

Table 3. Inhibition ratio of D-2HG (373 fold to αKG) and L-2HG (28 fold to αKG) on
ALKBH2 and ALKBH3.
Enzyme

Condition

% Inhibition of 373-fold
D-2H to αKG

% Inhibition of 28-fold
L-2HG to αKG

ss-m1A

86

53

ds-m1A

77

57

ss-m3C

88

48

ds-m3C

88

58

ss-m1A

80

40

ds-m1A

81

37

ss-m3C

73

32

ds-m3C

87

31

ALKBH2

ALKBH3
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αKG Recovery of 2HG’s Inhibition on the Repair Enzymes. Because 2-HG and
αKG are structurally similar, researchers hypothesized that 2HG is able to replace αKG
in the active site of αKG dependent enzymes and competitively inhibit their enzymatic
activities.7 Crystal structures of histone demethylases show that D-2HG binds to the
same site as αKG in the catalytic center.7 We tested the competition between 2HG and
αKG in the DNA repair reactions. Using ALKBH2 repair of m1A as an example, the
repair ratios without adding 2HG were controlled to be around 60% under different αKG
concentrations (0.1, 0.5 and 1.0 mM, Figure 4 and Table S6). For the inhibition
reactions, D-2HG was added at a fixed concentration (10 mM) in the reaction mixture,
which contained ALKBH2 and necessary cofactors. Then, different concentrations of
αKG were added and mixed. After that the reaction was initiated by adding the
oligonucleotide substrates. When 0.1 mM αKG was present, the conversion decreased
to 22%. When 0.5 mM and 1.0 mM αKG were added, the repair ratio increased to 35%
and 38%, respectively (Figure 4 and Table S6). This observed trend of reactivity
recovery is consistent with the notion that D-2HG acts as a competitive inhibitor in the
αKG-dependent DNA repair reactions.7 Similar recovery patterns were observed for all
other D- and L-2HG inhibition reactions on all three enzymes (Figure 4 and Table S6).
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Figure 4. Addition of αKG reverses the inhibitory effect of 2-HG toward ALKBH2
repair of m1A. Different concentrations of αKG were added to a fixed concentration of
2HG (10 mM) to recover the repair of m1A by a) ALKBH2, b) ALKBH3 and c) AlkB.
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DISCUSSION
Biological Implications of 2HG Inhibition of DNA Repair Enzymes. In the current
study, we have shown that both D- and L-enantiomers of the oncometabolite 2HG can
significantly inhibit the human DNA repair enzymes ALKBH2 and ALKBH3 under
physiologically relevant concentrations. The concentrations of D-2HG and αKG on
average in glioma cells are 15.5 µmol/g, and 0.0415 µmol/g, respectively, which
correspond to a concentration ratio between D-2HG and αKG of 373 to 1.6,7 Under this
ratio condition, the repair activities of ALKBH2 and ALKBH3 were 73-88% inhibited
(Table 3). The concentrations of L-2HG and αKG on average in kidney cancer cells are
1.15 µmol/g and 0.0484 µmol/g, respectively, which corresponds to a concentration
ratio between L-2HG and αKG of 28 to 1.10 Under this ratio condition, ALKBH2 and
ALKBH3’s repair activities are 31-58% inhibited (Table 3). Although the relative
concentration of L-2HG (1.15 µmol/g) is more than 10 times lower than D-2HG (15.5
µmol/g), the ALKBH2 and ALKBH3 enzymes are still soundly inhibited by L-2HG
partially due to the higher binding affinity of L-2HG (i.e., lower Ki) than D-2HG (Table
2). The extent of inhibition in both cases was measured when the concentration of αKG
was fixed at 100 µM, to ensure steady state catalysis. However, at lower concentrations
of αKG, (i.e., 50 or 20 µM), the efficiency of adduct repair decreased even further. The
cellular concentrations of αKG are typically around 40 to 50 µM (0.0415 and 0.0484
µmol/g or mM) in cancer patients,6,10 which are near to the 50-100 µM range used in
our experiments. Our data also show that, consistent with competitive inhibition of
2HG, the inhibition activity in the repair reaction reflects primarily the ratio between
2HG and αKG. ALKBH2 and ALKBH3 are enzymes that repair alkyl DNA damage;
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hence, inhibition of DNA repair leads to alkylation product accumulation, less cellular
survival, and increased mutations, which affect the resistance/sensitivity balance to
alkylating chemotherapeutics. The elevation of both D- and L-2HG in cancer cells may
contribute to the increased mutation rate and exacerbate tumorigenesis and progression.
Strand Preference of the Three Repair Enzymes. According to the literature,
ALKBH2 prefers to repair m1A and m3C in ds-DNA, whereas ALKBH3 and AlkB
prefer to repair those adducts in ss-DNA.24,30,55 We tested the repair activity in both ssDNA and ds-DNA substrates in this study. The experimental results reported in this
paper provide a strong kinetic basis for the previous observations. For ALKBH2, the
kcat/KM values of ds-repair are higher than the repair in ss-DNA (Table 1). By contrast,
the kcat/KM values of AlkB repair are higher for ss-DNA substrates than for ds-DNA
substrates (Table 1).

For ALKBH3, we were only able to measure the kinetic

parameters for ss-repair, as the ds-repair reactions were too inefficient to evaluate.
These results agree with and add quantitative detail to previous observations that
ALKBH3 strongly prefers to repair adducts in ss-DNA.
Other αKG/Fe(II)-Dependent Enzymes may be Inhibited by Oncometabolites.
There are about 80 proteins in the αKG/Fe(II)-dependent enzyme family, including jmjc,
prolyl hydroxylase, TET, and the AlkB family enzymes.21–23 Studies have demonstrated
that D- and L-2HG inhibit jmjc and TET family proteins.7,62 In addition to 2HG,
intermediates in the TCA cycle such as succinate and fumarate have also been found to
exhibit higher-than-normal concentrations in different cancer cells (Figure 1b).18 Given
their structural similarities to αKG and 2HG, these metabolites could also perturb αKGdependent enzymatic activities in the cell, especially DNA repair processes that are
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related to the AlkB family enzymes. Systematic studies are needed to explore these
possibilities and correlate these biochemical results with clinical observations. These
studies are also pivotal for the design and development of therapeutic agents that target
the abnormal metabolic pathways of cancer.
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Table S1. Calculated and observed molecular weight (MW) and m/z value of
oligonucleotides used in the enzymatic reactions.

The sequence of the 16mer

oligonucleotides was 5’-GAAGACCTXGGCGTCC-3’, where X indicates m1A or
m3C. The sequence of the complementary 23mer oligonucleotides was 5′CTGGGACGCCYAGGTCTTCACTG-3′, where Y represents the position opposite the
lesion site and contains the canonical bases T and G; these molecules were named 23Tcp and 23-Gcp, respectively. Additionally, 23mer oligonucleotides complementary to
23-Tcp

and

23-Gcp

were

also

synthesized

with

the

sequence

5′-

CAGTGAAGACCTZGGCGTCCCAG-3′, where Z denotes the regular bases A and C,
and named 23-A and 23-C, respectively.
Oligonucleotide

MW (calculated) m/z (calculate)
of neutral species
-4 charge peak

m/z (observed)
-4 charge peak

16mer m1A

4902.88

1224.71

1224.71

16mer m3C

4878.87

1218.71

1218.70

Oligonucleotide

MW (calculated) m/z (calculate)
of neutral species
-5 charge peak

m/z (observed)
-5 charge peak

23mer Tcp

7028.19

1404.63

1404.66

23mer Gcp

7053.19

1409.63

1409.66

23mer A

7055.22

1410.04

1410.06

23mer C

7031.21

1405.23

1405.26
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Table S2. Initial rate for kinetic studies of ALKBH2, ALKBH3 and AlkB on αKG as a
substrate under different conditions. The reaction rate is in µM/min.
αKG (μM)

ALKBH2 reaction Rate
ss-m1A

ds-m1A

5.0

0.10 ± 0.00

0.16 ± 0.01

10.0

0.11 ± 0.01

20.0

αKG (μM)

ALKBH2 reaction Rate
ss-m3C

ds-m3C

1.0

0.14 ± 0.00

0.10 ± 0.01

0.21 ± 0.03

3.0

0.22 ± 0.00

0.15 ± 0.01

0.14 ± 0.01

0.26 ± 0.03

5.0

0.29 ± 0.02

0.18 ± 0.03

30.0

0.15 ± 0.00

0.30 ± 0.02

10.0

0.30 ± 0.02

0.21 ± 0.02

50.0

0.16 ± 0.02

0.32 ± 0.03

20.0

0.32 ± 0.01

0.23 ± 0.02

0.35 ± 0.03

30.0

0.32 ± 0.03

0.25 ± 0.02

70.0
αKG (μM)

ALKBH3 reaction rate
ss-m1A

ss-m3C

5

0.20 ± 0.02

0.24 ± 0.00

10

0.24 ± 0.01

0.29 ± 0.01

20

0.26 ± 0.01

0.30 ± 0.01

30

0.28 ± 0.01

0.30 ± 0.02

50

0.28 ± 0.01

0.32 ± 0.01

70

0.28 ± 0.02

0.33 ± 0.01

αKG (μM)

AlkB reaction rate
ss-m1A

ds-m1A

ss-m3C

ds-m3C

5.0

0.17 ± 0.01

0.20 ± 0.02

0.31 ± 0.03

0.46 ± 0.04

10.0

0.25 ± 0.01

0.32 ± 0.05

0.49 ± 0.05

0.53 ± 0.04

20.0

0.30 ± 0.03

0.44 ± 0.02

0.75 ± 0.09

0.78 ± 0.07

30.0

0.35 ± 0.02

0.51 ± 0.02

0.87 ± 0.13

0.92 ± 0.04

50.0

0.34 ± 0.04

0.60 ± 0.01

1.04 ± 0.10

0.99 ± 0.09

70.0

0.39 ± 0.04

0.59 ± 0.04

1.17 ± 0.12

1.09 ± 0.06
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Table S3. Initial rate for kinetic studies of ALKBH2 and ALKBH3 on DNA adducts as
substrates.
ALKBH2 reaction rate
ssm1A
(μM)

V0
(μM/min)

dsm1A
(μM)

V0
(μM/min)

ssm3C
(μM)

V0
(μM/min)

dsm3C
(μM)

V0
(μM/min)

7.5

0.31 ± 0.02

5

0.26 ± 0.05

2.5

0.18 ± 0.01

2.5

0.22 ± 0.02

10

0.36 ± 0.03

7.5

0.34 ± 0.03

3.5

0.20 ± 0.01

5

0.25 ± 0.02

12.5

0.49 ± 0.02

10

0.41 ± 0.04

4.5

0.24 ± 0.02

7.5

0.30 ± 0.01

15

0.53 ± 0.05

12.5

0.47 ± 0.04

5.5

0.25 ± 0.02

10

0.37 ± 0.04

17.5

0.53 ± 0.08

15

0.52 ± 0.10

6.5

0.27 ± 0.02

12.5

0.41 ± 0.02

20

0.66 ± 0.03

17.5

0.53 ± 0.09

7.5

0.31 ± 0.04

15

0.42 ± 0.03

ALKBH3 reaction rate
ssm1A
(μM)

V0
(μM/min)

ssm3C
(μM)

V0
(μM/min)

7.5

0.30 ± 0.02

5

0.22 ± 0.01

10

0.33 ± 0.02

7.5

0.24 ± 0.01

12.5

0.35 ± 0.03

10

0.25 ± 0.01

15

0.36 ± 0.02

12.5

0.27 ± 0.01

17.5

0.37 ± 0.02

15

0.26 ± 0.01

20

0.38 ± 0.03

17.5

0.28 ± 0.01
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Table S4. Kinetic constants of ALKBH2 and ALKBH3 reactions on DNA adducts as
substrates.
Enzyme

Substrate

KM [µM]

kcat [min-1]

kcat / KM
[min-1·µM-1]

ss-m1A

35.9 ± 18.2

8.9 ± 3.2

0.25

ds-m1A

12.6 ± 1.4

9.3 ± 0.5

0.74

ss-m3C

4.4 ± 1.1

2.4 ± 0.3

0.53

ds-m3C

5.0 ± 1.5

5.5 ± 0.6

1.10

ss-m1A

3.5 ± 0.2

1.8 ± 0.0

0.52

ss-m3C

1.9 ± 0.5

1.2 ± 0.1

1.03

ALKBH2

ALKBH3
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Table S5. 2-HG inhibition on ALKBH2 demethylation of ss- and ds-m1A.
D-2HG inhibition on ALKBH2 demethylation of ss-m1A.
Product D-2HG
/μM /mM

0.0

1.0

3.0

5.0

9.0

Time/min

3

1.23 ± 0.07 1.07 ± 0.06 0.80 ± 0.03 0.61 ± 0.05 0.47 ± 0.04

6

1.43 ± 0.07 1.22 ± 0.07 0.93 ± 0.05 0.69 ± 0.05 0.55 ± 0.02

9

1.50 ± 0.06 1.29 ± 0.07 0.99 ± 0.04 0.70 ± 0.02 0.57 ± 0.04

12

1.67 ± 0.06 1.44 ± 0.05 1.11 ± 0.04 0.82 ± 0.04 0.63 ± 0.03

15

1.78 ± 0.08 1.51 ± 0.08 1.18 ± 0.03 0.89 ± 0.04 0.70 ± 0.03

D-2HG inhibition on ALKBH2 demethylation of ds-m1A
D-2HG
/mM
/μM
Time/min
Product

0.0

1.0

3.0

5.0

9.0

5

1.54 ± 0.04 1.20 ± 0.08 0.85 ± 0.02 0.59 ± 0.07 0.37 ± 0.15

8

1.68 ± 0.11 1.43 ± 0.03 0.96 ± 0.02 0.74 ± 0.12 0.44 ± 0.10

11

1.67 ± 0.01 1.55 ± 0.19 1.06 ± 0.22 0.81 ± 0.13 0.52 ± 0.02

14

1.85 ± 0.01 1.59 ± 0.13 1.08 ± 0.11 0.82 ± 0.11 0.52 ± 0.06

D-2HG inhibition on ALKBH2 demethylation of ss-m1A and ds-m1A under 373 fold
to αKG condition.
D-2HG
Repair
/mM
ratio %

0.0

9.0

37.3

ss-m1A

93.9 ± 6.4

37.2 ± 1.5

12.7 ± 0.1

ds-m1A

97.7 ± 1.6

37.8 ± 2.8

22.3 ± 0.8

Substrate
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L-2HG inhibition on ALKBH2 demethylation of ss-m1A
L-2HG
/mM
/μM
Time/min
Product

0.0

1.0

3.0

5.0

9.0

3

1.34 ± 0.05 0.82 ± 0.03 0.54 ± 0.02 0.43 ± 0.03 0.34 ± 0.03

6

1.61 ± 0.05 1.04 ± 0.03 0.67 ± 0.01 0.53 ± 0.05 0.44 ± 0.00

9

1.62 ± 0.04 1.13 ± 0.08 0.72 ± 0.02 0.59 ± 0.02 0.46 ± 0.01

12

1.84 ± 0.09 1.28 ± 0.07 0.85 ± 0.02 0.68 ± 0.01 0.53 ± 0.01

15

1.96 ± 0.09 1.33 ± 0.07 0.92 ± 0.04 0.73 ± 0.02 0.54 ± 0.03

L-2HG inhibition on ALKBH2 demethylation of ds-m1A
L-2HG
/mM
/μM
Time/min
Product

0.0

1.0

3.0

5.0

9.0

5

2.21 ± 0.14 1.19 ± 0.09 0.67 ± 0.07 0.48 ± 0.05 0.38 ± 0.04

8

2.56 ± 0.13 1.74 ± 0.03 0.95 ± 0.03 0.61 ± 0.06 0.43 ± 0.02

11

2.84 ± 0.22 2.05 ± 0.12 1.12 ± 0.07 0.79 ± 0.08 0.51 ± 0.03

14

2.94 ± 0.03 2.18 ± 0.08 1.04 ± 0.31 0.85 ± 0.03 0.54 ± 0.03

L-2HG inhibition on ALKBH2 demethylation of ss-m1A and ds-m1A under 28 fold to
αKG condition.
Repair
ratio %

L-2HG
/mM

0.0

1.0

2.8

ss-m1A

80.8 ± 0.9

55.1 ± 2.9

38.3 ± 0.5

ds-m1A

85.0 ± 1.2

65.1 ± 2.0

37.0 ± 0.5

Substrate
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Table S6. Addition of αKG reverses the inhibitory effect of 2HG toward ALKBH2,
ALKBH3 and AlkB. Both D-2HG and L-2HG concentrations were fixed at 10.0 mM.
ALKBH2
Repair Group
ratio%
No
Dinhibitor 2HG
αKG
61.5± 22.0±
0.1 mM
1.5
0.7
66.0± 35.1±
0.5 mM
0.6
0.8
63.9± 38.1±
1.0 mM
0.5
1.1

ALKBH3
L2HG
10.9±
0.5
21.5±
0.6
25.5±
0.4

No
inhibitor
60.0±
1.3
59.4±
0.1
57.9±
1.6

D2HG
37.0±
0.6
43.3±
0.9
46.6±
2.2

AlkB
L2HG
20.9±
1.1
34.2±
1.9
39.2±
0.6

No
inhibitor
66.0±
0.2
65.8±
0.3
65.0±
0.3

D2HG
24.2±
0.4
29.2±
1.1
29.0±
0.7

L2HG
30.2±
1.5
36.9±
1.7
40.2±
2.6

Table S7: IC50 (50% inhibition concentration) of L-2HG, D-2HG and N-OG on
ALKBH2, ALKBH3 and AlkB.
IC50 [mM]
Enzyme

Adduct
D-2HG

L-2HG

N-OG

ss-m1A

10.3 ± 1.6

7.0 ± 1.1

0.8 ± 0.2

ds-m1A

4.7 ± 0.8

2.7 ± 0.5

0.2 ± 0.1

ss-m3C

10.9 ± 1.0

4.6 ± 0.2

2.9 ± 0.5

ds-m3C

4.2 ± 0.6

4.1 ± 0.6

0.4 ± 0.1

ss-m1A

24.3 ± 3.5

8.3 ± 1.0

1.2 ± 0.2

ss-m3C

26.4 ± 2.5

12.3 ± 0.8

2.0 ± 0.2

ss-m1A

8.6 ± 2.5

5.1± 1.5

6.7E-03±1.5E-03

ds-m1A

4.7 ± 1.1

5.3 ± 1.5

1.8E-02±1.1E-02

ss-m3C

2.7 ± 0.7

1.7 ± 0.7

2.3E-03±0.6E-03

ds-m3C

2.4 ± 0.6

3.2 ± 1.1

1.7E-03±0.3E-03

ALKBH2

ALKBH3

AlkB
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Figure S1. Steady-state kinetic studies probing the influence of αKG on adduct
demethylation reactions catalyzed by ALKBH2. Data are in Table S2.
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Figure S2. Steady-state kinetic studies probing the influence of αKG on adduct
demethylation reactions catalyzed by ALKBH3. Data are in Table S2.
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Figure S3. Steady-state kinetic studies probing the influence of αKG on adduct
demethylation reactions catalyzed by AlkB. Data are in Table S2.
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Figure S4. Steady-state kinetic studies probing the influence of adducts in the
demethylation reactions catalyzed by ALKBH2 and ALKBH3. Data are in Table S3.
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Repair percentage
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4.0
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20
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100
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930

Figure S5. The repair percentage of AlkB on ss-m1A under various concentrations of
αKG. Y-axis represents the percentage conversion of starting material m1A to product
A.

Figure S6. Inhibition of ALKBH2-mediated ss-m1A repair by D-2HG, L-2HG and NOG. Left: D-2HG, middle: L-2HG and right: N-OG.
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Figure S7. Inhibition of ALKBH2-mediated ss-m3C repair by D-2HG, L-2HG and NOG. Left: D-2HG, middle: L-2HG and right: N-OG.

Figure S8. Inhibition of ALKBH2-mediated ds-m1A repair by D-2HG, L-2HG and NOG. Left: D-2HG, middle: L-2HG and right: N-OG.
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Figure S9. Inhibition of ALKBH2-mediated ds-m3C repair by D-2HG, L-2HG and NOG. Left: D-2HG, middle: L-2HG and right: N-OG.

Figure S10. Inhibition of ALKBH3-mediated ss-m1A repair by D-2HG, L-2HG and NOG. Left: D-2HG, middle: L-2HG and right: N-OG.
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Figure S11. Inhibition of ALKBH3-mediated ss-m3C repair by D-2HG, L-2HG and NOG. Left: D-2HG, middle: L-2HG and right: N-OG.

Figure S12. Inhibition of AlkB-mediated ss-m1A repair by D-2HG, L-2HG and N-OG.
Left: D-2HG, middle: L-2HG and right: N-OG.
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Figure S13. Inhibition of AlkB-mediated ss-m3C repair by D-2HG, L-2HG and N-OG.
Left: D-2HG, middle: L-2HG and right: N-OG.

Figure S14. Inhibition of AlkB-mediated ds-m1A repair by D-2HG, L-2HG and N-OG.
Left: D-2HG, middle: L-2HG and right: N-OG.
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Figure S15. Inhibition of AlkB-mediated ds-m3C repair by D-2HG, L-2HG and N-OG.
Left: D-2HG, middle: L-2HG and right: N-OG.
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ABSTRACT
Disturbed metabolism of copper ions can cause diseases, such as Wilson’s disease
(WD). In this work, we investigated the inhibitory effect of Cu(II) ion on the AlkB
family DNA repair enzymes, which are members of the Fe(II)/αKG-dependent
dioxygenase and includes human ALKBH2, ALKBH3, and E. coli AlkB proteins. None
of the three proteins were significantly inhibited under normal cellular copper
concentrations. But under WD related condition, we observed the activities of all three
enzymes were strongly suppressed (inhibition from 95.2 to 100.0%). We also noted the
repair efficiency under ds-DNA condition is less susceptible than ss-DNA to the
inhibition.
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Copper is an essential yet toxic metal for human physiological functions and the cellular
concentrations of its ions, such as Cu(II) and Cu(I) ions, are tightly regulated. If the
concentrations of these ions are dysregulated, certain diseases, such as Wilson’s disease
(WD), may occur.1,2 For patients under WD condition, the level of copper in human
liver samples raises as much as 249.9 ng/mg (dry weight), which is significantly higher
(more than 10 fold) than the level in normal cells (21.5 ng/mg).1 These elevated copper
levels create an inflammatory cellular environment in liver tissue cells and damage their
lipid bilayers, thus forming a variety of DNA adducts. Nair et. al have reported the
ethenoadenine (eA) and ethenocytosine (eC) DNA lesions are significantly increased
under WD condition.1,3 These etheno DNA lesions are substrates of the AlkB family
DNA repair enzymes, such as the human homologs ALKBH2 and 3, which use an
Fe(II)/alpha-ketoglutarate (αKG)-dependent mechanism to oxidize the abnormal alkyl
groups, ultimately restoring the undamaged DNA bases.4 Previously, the copper(II) ion
has been reported to replace the Fe(II) ion in AlkB in a spectroscopic study, and to
inhibit several Fe(II)/αKG family enzymes, such as JMJD2A, JMJD2E and PHD2.5–7
Several divalent ions, such as Ni2+, Co2+ and Mn2+, have been demonstrated to inhibit
other enzymes in this family, such as C-P4H, PLOD1, FIH, TauD, JMJD1A and
ALKBH2.5,8 It is reasonable to predict, then, that the high level of copper ions
accumulated under WD condition inhibits the DNA repair capacity of both ALKBH2
and 3. Therefore the elevated level of copper ions found in WD condition induces
damages and increases the number of etheno adducts within the cell in a “two-fold”
manner; it not only induces alkyl DNA damage through lipid peroxidation but also
suppresses the repair of those adducts from the AlkB family DNA repair enzymes.
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The AlkB protein in E. coli was discovered to be an Fe(II)/αKG- dependent dioxygenase
that repairs various alkyl DNA lesions (Figure 1).9,10 Nine human homologs of AlkB
have been identified as ALKBH1-8 and FTO. Among these homologs, ALKBH2 and
ALKBH3 have been characterized as DNA repair proteins.11,12 A variety of alkyl DNA
lesions have been proven as substrates for AlkB, ALKBH2 and ALKBH3, both in vitro
and in vivo. The lesions include methyl adducts, like 3-methylcytosine (m3C) and 1methyladenine, etheno adducts, such as eA and eC, and other lesions with complex alkyl
modifications to the DNA bases.12 Among those adducts, m3C and m1A have been
reported as the best substrates for the AlkB family enzymes.11,12 Previous in vitro
studies on the inhibition of other Fe(II)/αKG-dependent enzymes by Cu(II) ion have
only provided the IC50 values and the results have not been extrapolated to
physiologically and pathologically relevant concentrations.6 In this work, for the first
time we not only measured the IC50 values of Cu(II) ion on the ABH2, ABH3, and AlkB
proteins but also tested the inhibitory effects under normal cellular and Wilson’s disease
condition.
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Figure 1. Repair mechanism of the AlkB family enzymes on alkyl DNA lesions and the
inhibition of repair by Cu(II) ion. Adduct m3C is used here as an example to show the
enzymatic catalysis.

To test the inhibitory effect of Cu(II) ion on the AlkB family enzymes, we first sitespecifically synthesized a 16mer oligonucleotide containing m3C, the major substrate
of the AlkB family enzymes.12,13 We expressed and purified recombinant human
ALKBH2 and ALKBH3 proteins, and the E. coli AlkB protein.14 Then, we evaluated
the repair efficiency of the enzymes (Figure S1) and the inhibitory effect of Cu(II) ion
under different conditions. It has been reported that the cellular concentrations of “free”
copper and iron ions are very limited.

Under normal cellular conditions, the

concentration of free copper ions is 1.5 µM, which is 1.5 fold greater than free iron ions
(1.0 µM). For the WD patients, the level of free copper ion is increased to 24.4 µM.15
In this work, we tested different Fe(II) ion concentrations and selected 5.0 µM to ensure
the maximal efficiency of repair by the AlkB family enzymes (Figure S2); this
concentration was similar to the Fe(II) ion concentrations used in other inhibition
studies.6 The inhibitory effects of Cu(II) ion were tested from 0.0 to 100.0 µM, among
which 7.5 µM of Cu(II) was used to mimic normal cellular condition. Though the
cellular levels of copper ion under WD condition vary considerably from different
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reports, all of the levels are more than 10 fold higher than the normal cellular
concentration.1,2,15 To make this work rigorous and relevant to pathological disease
condition, we used 75.0 µM (10 fold) of copper ion to represent the WD condition.
For each enzymatic reaction, the m3C-containing oligonucleotides were incubated with
the necessary cofactors for the AlkB reaction: Fe(II) ion, αKG, and ascorbic acid (see
Experimental Section in Supporting Information) in either ss- or ds-DNA. In a typical
inhibition test (e.g., ALKBH2 repairing m3C), 5.0 µM of oligonucleotide substrate, and
2.0 µM ALKBH2 enzyme were mixed with a fixed concentration of Fe(II) ion (5.0 µM)
plus different concentrations of Cu(II) ion, and the extent of the repair reaction was
quantified (see Experimental Section for details). Because the AlkB family enzymes
are able to repair DNA lesions in both ss- and ds-DNA, the repair reactions of m3C
were carried out under both conditions.
For the Cu(II) ion inhibition of the ALKBH2 repair reaction on m3C in ss- and ds-DNA
(Figure 2 and Table S1), the IC50 values are 14.8 μM and 54.0 μM, respectively (Table
1). The IC50 values for AlkBH3 and AlkB were also measured (Table 1). From the IC50
tests, we found the IC50 values are higher in ds-DNA condition than ss-DNA condition
for all three enzymes, despite the preference of AlkBH3 and AlkB to repair m3C in ssDNA and AlkBH2 preferring repair in ds-DNA.12 These results shows the repair under
ds condition is less susceptible than ss condition to the inhibition from Cu(II) ion. One
possibility is that copper ion is harder to access to the active site of an enzyme and
replace its iron ion due to the more crowded environment under ds-DNA binding
condition.
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Figure 2. IC50 measurements of Cu(II) ion on the repair of m3C by AlkBH2, AlkBH3,
and AlkB under ss- and ds-DNA conditions.
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Table 1. IC50 values of Cu(II) ion inhibiting the AlkB family enzymes. The repair
reactions of m3C were carried out under both ss- and ds-DNA conditions.
Protein

Substrate

IC50 (µM)

ss-DNA

14.8

ds-DNA

54.0

ss-DNA

23.8

ds-DNA

28.4

ss-DNA

10.3

ds-DNA

29.3

ALKBH2

ALKBH3

AlkB

We then tested the inhibition of Cu(II) ion under normal physiological condition with
the concentration at 7.5 µM. We found that none of the three proteins were significantly
inhibited under this concentration, with the highest inhibition at 7.0% for ALKBH3
repairing m3C in ds-DNA. (Table S2 in SI). These results indicated that the repair
efficiency of the AlkB family enzymes are barely affected by Cu(II) ions under normal
cellular conditions. Next, we tested the inhibition of Cu(II) ions under WD condition
with the concentration of Cu(II) ion at 75.0 µM. We found all three enzymes were
strongly inhibited under WD condition (inhibition from 95.2 to 100.0%, Table S2).
In this work, we used m3C, the best substrate of AlkB, to demonstrate the AlkB family
enzymes are strongly inhibited by high concentration of Cu(II) ion under WD condition.
Other substrates, such as the etheno DNA lesions will be tested both in vitro and in vivo
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in the future, which will provide a new explanation to the previously observed elevation
of etheno adducts in Wilson’s disease.1

Considering that there are about eighty

Fe(II)/αKG-dependent enzymes in human body,11 it is highly possible that some of those
enzymes could be inhibited in a similar mechanism by the high concentrations of the
copper ion under Wilson’s disease condition.
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Figure S2. Dose-response curve of Fe(II) ions to the AlkB repair activity on m3C. In
each reaction, 5.0 µM of oligonucleotide substrate, and 2.0 µM AlkB enzyme were
mixed with different concentrations of Fe(II) ion, and the extent of the repair reaction
was quantified.
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Table S1. Cu(II) ion inhibition on the demethylation of m3C by the AlkB family
enzymes in ss- and ds-DNA. The data indicate the percentiles of repair. Each reaction
was performed in triplicate.
ALKBH2

ALKBH3

AlkB

Cu(II)/µM
ss-DNA

ds-DNA

ss-DNA

ds-DNA

ss-DNA

ds-DNA

0.0

92.6 ± 3.5

100.0 ± 0

100.0 ± 0

77.6 ± 3.1

100.0 ± 0

100.0 ± 0

5.0

92.1 ± 2.4 97.9 ± 3.7

100.0 ± 0

75.5 ± 2.1 99.7 ± 0.1

100.0 ± 0

7.5

88.5 ± 0.6 98.1 ± 3.2

100.0 ± 0

72.2 ± 0.5 98.3 ± 0.5

100.0 ± 0

10.0

75.9 ± 0.5 99.0 ± 1.7

100.0 ± 0

66.4 ± 3.6 54.8 ± 3.6

100.0 ± 0

20.0

6.5 ± 3.1

98.5 ± 1.4 74.7 ± 5.5 51.9 ± 3.1

30.0

1.0 ± 0.3

90.1 ± 3.2

8.7 ± 0.8

40.0

0±0

76.5 ± 2.7

50.0

0±0

75.0
100.0

2.6 ± 0.3

98.9 ± 1.0

35.5 ± 1.7

0.6 ± 0

45.3 ± 2.3

1.2 ± 1.1

25.7 ± 1.7

0±0

19.1 ± 1.5

54.4 ± 6

0.6 ± 1.1

16.7 ± 2.7

0±0

8.4 ± 0.7

0±0

4.0 ± 1.4

0±0

3.7 ± 1.2

0±0

2.0 ± 0.6

0±0

0.4 ± 0.6

0±0

1.7 ± 0.2

0±0

0±0

Table S2. Cu(II) ion inhibition on the demethylation of m3C by the AlkB family
enzymes under normal and Wilson’s Disease conditions. The data indicate the
percentiles of inhibition. Each reaction was performed in triplicate.
Cu/Fe
ratio

ALKBH2

ALKBH3

AlkB

ss-DNA ds-DNA ss-DNA ds-DNA ss-DNA ds-DNA

Normal

1.5

4.4

1.9

0.0

7.0

1.7

0.0

Wilson's
Disease

15.0

100.0

96.0

100.0

95.2

100.0

98.0
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Experimental Section
Oligonucleotide Synthesis. The synthesis of oligonucleotides (ODNs) were described
previously.1,2

Briefly, the 16mer DNA oligonucleotide with the sequence 5′-

GAAGACCTXGGCGTCC-3′ (X represents the 3-methylcytosine), the complementary
23merGcp

5′-CTGGGACGCCGAGGTCTTCACTG-3′

CAGTGAAGACCTCGGCGTCCCAG-3′,

were

and

synthesized

23merC
by

5′-

MerMade-4

oligonucleotide synthesizer. All ODNs were purified by HPLC (Thermo Fisher
Scientific) with a DNAPac PA-100 Semi-Preparative column (Thermo Fisher
Scientific). Solvent A of 100 mM mixture (1:1) of triethylamine-acetic acid in water
and solvent B 100% acetonitrile were employed as mobile phases. The concentration of
DNA was determined by NanoDrop (Thermo Fisher Scientific) with UV absorbance at
260 nm. The ODNs were characterized by HPLC−electrospray ionization triple
quadrupole time-of-flight mass spectrometry (AB Sciex).
Expression and Purification of the AlkB, ALKBH2, and ALKBH3 Proteins. The
expression and purification of AlkB, ALKBH2, and ALKBH3 were described
previously.1,2 Briefly, His-tagged AlkB was obtained by transforming pET-28a(+)AlkB into E. coli Rosetta2(DE3)pLysS (BL21(DE3)pLysS for ALKBH2 and
ALKBH3) cells, followed by adding 1 mM isopropyl β-D-thiogalactopyranoside
(IPTG) to induce the expression at 37 °C (37 °C for ALKBH2 and 30 °C for ALKBH3).
The expressed proteins were purified by FPLC (GE healthcare) with an affinity
chromatography column.

The His-tag was removed by thrombin and the final

purification step used ion-exchange column chromatography.
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Enzymatic Reaction. The AlkB family demethylase activity reactions on ss- and dsDNA were described previously.1,2 All reactions were performed at 37°C in reaction
buffer [5 μM Fe(NH4)2(SO4)2, 0.93 mM α-ketoglutarate, 1.86 mM ascorbic acid, and
46.5 mM HEPES (pH 8.0) ] for 1 hour. Varying concentrations of copper (II) chloride
(0.0, 5.0, 7.5, 10.0, 20.0, 30.0, 40.0, 50.0, 75.0, and 100.0 μM) were used for the
inhibition tests. 16mer-m3C (ss- or ds-DNA) was pre-mixed with reaction buffer in a
concentration of 5.0 µM. The reactions were initiated by adding 0.2 µM AlkB (2.0 µM
for ALKBH2 and ALKBH3). The reactions were stopped by adding 10.0 mM EDTA
followed by heating to 95 °C for 5 min. For reactions with ds-DNA, most steps were
identical to ss-DNA reactions, except 16mer m3C containing ODN was annealed to
23mer complimentary strand (23mer-Gcp) before reaction. The reaction was terminated
by adding excessive amount of 23merC ODN, which was the perfect complement to
23mer-Gcp, with 10 mM EDTA, then heated up to 95°C and slowly cooled down to
room temperature. Each reaction was performed in triplicate. All the results of reaction
were analyzed by HPLC.
HPLC conditions. All reaction samples were quantified by DNApac PA-100 column
(4 mm × 250 mm, Thermo Scientific) with isocratic 60% mobile B, 1.5 M ammonium
acetate, under a constant flow rate of 1.0 mL/min. Mobile A was water. The UV
detection wavelength was 260 nm.
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ABSTRACT
5-Methylcytosine (5mC) in DNA CpG islands is an important epigenetic biomarker for
mammalian gene regulation. It is oxidized to 5-hydroxymethylcytosine (5hmC), 5formylcytosine (5fC), and 5-carboxylcytosine (5caC) by the ten-eleven translocation
(TET)

family

enzymes,

which

are

α-ketoglutarate

(α-KG)/Fe(II)-dependent

dioxygenases. In this work, we demonstrate that the epigenetic marker 5mC is
biochemically modified to 5hmC, 5fC, and 5caC by another class of α-KG/Fe(II)dependent proteins – the DNA repair enzymes in the AlkB family, which include human
ALKBH2, ALKBH3, and AlkB in E. coli. Theoretical calculations indicate that these
enzymes may bind 5mC in the syn-conformation, placing the methyl group comparable
to 3-methylcytosine, the prototypic substrate of AlkB. This is the first demonstration of
the AlkB proteins to oxidize a methyl group attached to carbon, instead of nitrogen, on
a DNA base. These observations suggest a broader role in epigenetics for these DNA
repair proteins.
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INTRODUCTION
In mammals, methylation at the 5-position of cytosine (5-methylcytosine, 5mC, Figure
1) is the major form of DNA modification and occurs mainly on CpG dinucleotide
sites.(1–3) This methylation is achieved and maintained by S-adenosylmethioninedependent methyltransferases.(4) The reverse process termed demethylation of 5mC is
first carried out by the ten-eleven translocation proteins (TET1, 2, and 3) through
iterative oxidation of 5mC to 5-hydroxymethycytosine (5hmC), 5-formylcytosine (5fC)
and 5-carboxylcytosine (5caC) (Figure 1). Subsequently, the oxidation products 5fC and
5caC are removed and repaired back to unmethylated cytosine by thymine DNA
glycosylase coupled with base excision repair.(1, 5–8) The 5mC modification and its
three oxidative derivatives play important roles in epigenetic regulations and cell
development: they function in transcriptional regulation, gene silencing and
reprogramming.(1, 5) The misregulations of 5mC and derivatives have been associated
with cancer and other diseases.(1, 9, 10)
The TET family enzymes belong to the α-ketoglutarate (α-KG)/Fe(II)-dependent
dioxygenases; they have been extensively studied in the last decade for their biological
functions, biochemical activities and structural features.(1, 5, 6, 11) In the structures of
the TET enzymes, the highly conserved N-terminal β-hairpin-like element for DNAbase recognition and the C-terminal catalytic domain are also found in another family
of α-KG/Fe(II)-dependent nucleic acid-modifying dioxygenases, the AlkB family
proteins.(5, 12, 13) In this work, we show that the epigenetic modulator 5mC is modified
in vitro to 5hmC, 5fC, and 5caC by the DNA repair enzymes in the AlkB family,
including human ALKBH2, ALKBH3, and its Escherichia coli (E. coli) homolog AlkB
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(Figure 1). The results suggest that these DNA repair enzymes may play a wider role in
epigenetic modulation.

Figure 1. Reaction pathway of the AlkB family DNA repair enzymes modifying 5mC
and 3mC.

Different homologs of the E. coli AlkB protein exist in prokaryotic and eukaryotic
species; nine homologs exist in human cells (ALKBH1-8 and FTO).(12, 14) Among the
nine homologs, ALKBH2 and ALKBH3 are DNA repair enzymes that protect the
informational integrity of the genome.(5, 14–18) They use an α-KG/Fe(II)-dependent
mechanism to oxidize aberrant alkyl groups, ultimately restoring the undamaged DNA
bases.(14, 17, 18) The reported substrate scope of AlkB, ALKBH2 and ALKBH3
includes 3-methylcytosine (3mC, Figure 1), 1-methyladenine (1mA), 3-methylthymine
(3mT) and 1-methylguanine (1mG), as well as other nitrogen-attached methyl lesions
occurring at the Watson-Crick base pairing interface of DNA bases.(15, 16, 18–20)
Key structural information about the AlkB family enzymes has been obtained from
crystal structures of AlkB and ALKBH2 bound to lesion-containing DNA, which reveal
that their active sites share several characteristics. Specifically, the AlkB (ALKBH2 in
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brackets) complex contains a metal center Fe(II) in the wild-type enzymes) coordinated
to H131 (H171), H187 (H236), D133 (D173), α-KG, and molecular oxygen.(13, 21)
Repair of 3mC or 1mA has been proposed to be further enhanced by interactions
between D135 of AlkB (E175 of ALKBH2) and the exocyclic amino groups of the
lesion.(22) Interestingly, all crystal structures of the AlkB enzymes indicate the lesions
are bound in the anti glycosidic bond conformation (e.g., for 3mC: χ; ∠(O4′C1′N1C2)
= 180° ± 90°, Figure S18a.)

Although both 5mC and 3mC carry a methyl modification, the methyl groups are on
the opposite sides of the pyrimidine ring. It is reasonable to predict that members of the
AlkB enzyme family may be able to oxidize 5mC if the methyl group can be positioned
near the catalytic center. The in vitro experimental results demonstrated here reveal that
the AlkB enzymes can not only repair DNA lesions, such as 3mC, but also modify the
epigenetic biomarker 5mC and generate its oxidative derivatives. Our theoretical
calculations suggest that AlkB enzymes bind 5mC in the syn glycosidic conformation
(χ = 0° ± 90°, Figure S18b) to align the 5-methyl moiety for oxidation, which is similar
to how the TET family enzymes bind 5mC. This paper is the first work to demonstrate
the ability of the AlkB family enzymes to oxidize a methyl group that is attached to
carbon, instead of nitrogen, on a DNA base.
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MATERIAL AND METHODS
Synthesis of oligonucleotides containing 5mC and other modifications.

All

oligonucleotides used in this study were synthesized by solid-phase synthesis.(23–26)
The 5mC and other phosphoramidites was purchased from Glen Research. Synthetic
oligonucleotides were purified by reverse-phase HPLC and identified by electrospray
ionization mass spectrometry (ESI-MS).
Protein expression and purification. The expression and purification of ALKBH2,
ALKBH3 and AlkB proteins were described by previous published papers.(23, 24)
ALKBH2

and

ALKBH3

in

storage

buffer

containing

50

mM

N-

[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid (TAPS), 300 mM NaCl, 10%
glycerol, and 1 mM 2-mercaptoethanol, pH 8.0, AlkB in similar storage buffer (10 mM
Tris, 100 mM NaCl, 1 mM 2-mercaptoethanol, 10% glycerol, pH 8.0), were all stored
at -80 °C.
Enzymatic reaction. The reactions were performed based on previous published
procedures.(23, 24) A 16mer oligonucleotide containing one 5mC with sequence of 5’GAAGACCT-5mC-GGCGTCC-3’ was used as the substrate. One hundred pmol 16mer
5mC was mixed into reaction buffer (5 μM Fe(NH4)2(SO4)2, 0.93 mM α-ketoglutarate,
1.86 mM ascorbic acid, and 46.5 mM TAPS, pH 7.0) in a total volume of 16 µL. The
reactions were started by adding proteins (170 pmol AlkB, 140 pmol ALKBH2 or 128
pmol ALKBH3), and incubated at 37 °C for 1 hour. EDTA was employed to quench
the reactions and the reaction mixture was immediately heated up to 80 °C for 5min. A
16/23mer duplex DNA was preannealed as the substrate for dsDNA reaction.(24, 25)
The 23mer oligonucleotide is complementary to the 16mer sequence plus 7 nucleotides
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longer with the sequence of 5’-CTGGGACGCCGAGGTCTTCACTG-3’. The rest
steps of dsDNA reaction were the same as ssDNA reaction described above. All
reactions were carried out in triplicates.
Oligonucleotide digestion.

The procedures of oligonucleotide digestion to

deoxyribonucleoside were adopted from published procedure.(27) A digestion mixture
was premade by adding 250 Units Benzonase (Sigma-Aldrich, MO), 300 mUnits
phosphodiesterase I (Sigma-Aldrich, MO) and 200 Units alkaline phosphatase (SigmaAldrich, MO) to 5 mL Tris-HCl buffer (20 mM, pH 7.9) containing 100 mM NaCl and
20 mM MgCl2. Reaction of oligonucleotide containing 5mC with AlkB was quenched
by heating up to 80°C for 5 min, then digested by adding 50 µL digestion mixture and
incubating at 37°C for 6 hours. The nucleoside products were analyzed by HPLC-MS.
Samples were chromatographed on a Luna Omega Polar C18 column (150 X 4.6 mm,
5µm, 100Å, Phenomenex, CA) eluted at 1 mL/min with an acetonitrile gradient (1%15%). ESI triple quadrupole time of flight mass spectrometry was conducted to detect
nucleoside signals in the negative ion mode. Standard deoxyribonucleosides (including
dA, dT, dC, dG, 5mdC, 5hmdC, 5fdC and 5cadC) were purchased from Berry &
Associates (MI).
Protein digestion. The trypsin digestion of wide type AlkB and its variants were set
up according to Trypsin-ultraTM kit (New England Biolabs, MA). Ten µg of AlkB
proteins were mixed with 250 ng trypsin in trypsin-ultra buffer, incubating at 37 °C
overnight. The protein fragments were analyzed by HPLC-MS.(24, 26) Standard
protein fragments (including LFYHGIQPLK and LSLHQDK sequences) were
purchased from New England Peptide (MA).
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Preparing catalytically inactive variants of AlkB. The AlkB H131A, D133A, and
H187A variants were generated by QuikChange Mutagenesis (Agilent), using pET24aAlkBΔN11 as the PCR template and primer pairs encoding the desired mutations. All
three variants were purified essentially as described.(28) Briefly, One Shot BL21 Star
(DE3)pLysS E. coli cells (Invitrogen) transformed with an AlkB variant construct were
grown at 37 °C until OD600 had reached ~0.4, at which point the temperature was
lowered to 30 °C and protein production was induced by addition of 1 mM IPTG. Cells
were harvested after 4 h and stored at −80 °C until use. For purification, cell pellets
were resuspended in lysis buffer (10 mM Tris, pH 7.3, 300 mM NaCl, 2 mM CaCl2, 10
mM MgCl2, 5% (v/v) glycerol, 1 mM 2-mercaptoethanol) and lysed by sonication.
After clarification by centrifugation, the lysate was loaded onto a Ni-NTA column
(Qiagen), the column was washed twice with lysis buffer supplemented with 10 mM
and 20 mM imidazole, and bound protein was eluted with lysis buffer supplemented
with 70 mM and 250 mM imidazole. Elution fractions containing AlkB, as assessed by
SDS-PAGE, were combined and dialyzed for 16 h against 50 mM 2-[[1,3-dihydroxy-2(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid (TES), pH 7.1 with or without
20 mM NaCl, and loaded onto a 5 mL HiTrap SP cation exchange column (GE
Healthcare). Bound AlkB was eluted with a linear gradient of 0.02 – 1 M NaCl over 12
column volumes (60 mL). Fractions containing pure AlkB were pooled and purity was
established by SDS-PAGE.
Computational methodology. X-ray crystal structures of AlkB (PDB ID: 3O1S)(22)
and ALKBH2 (PDB ID: 3RZJ)(21) bound to lesion-containing DNA were chosen as
initial structures. The 3O1S crystal structure contains AlkB bound to an oxidized 3mC
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intermediate-containing DNA, Fe(II) ion, and succinate. The oxidized intermediate was
reverted to 3mC, and a water molecule bound to Fe(II) was modelled as an oxo ligand
to generate the Fe(IV)–oxo complex. To generate the active Fe(IV)–oxo ALKBH2
complex, the cofactors (Fe(IV), succinate, and oxo ligand) and metal-binding amino
acids (H131, D133, and H187) of the AlkB complex were super imposed onto the
cofactors (Mn(II) and α-KG) and metal-binding amino acids (H171, D173, and H236)
of the ALKBH2 complex. Hydrogen atoms were assigned using the tLEaP AMBER
utility.(29) Protonation states of ionizable amino acids were initially assigned using
H++(30) and adjusted using chemical intuition. For AlkB, H66, H97, H172, and H197
were assigned epsilon protonation, while H72, H131, and H187 were assigned delta
protonation. For ALKBH2, H55, H59, H106, H144, and H228 were assigned epsilon
protonation, H199 and H220 were assigned delta protonation, and H167 was modelled
as cationic. All crosslinks induced to facilitate crystallization between DNA and protein
were removed for both complexes. The G169C, C67S, C165S, and C192S mutations
to ALKBH2 were reverted to generate the wild-type enzyme, and the overhanging DNA
ends (residues 259, 260, and 284) were truncated. To generate the AlkB–5mC or
ALKBH2–5mC complexes, the anti and syn conformations of the 5mC nucleotide were
overlaid onto the 3mC substrate in the ALKBH2- or AlkB-DNA complex using
chemical intuition to minimize steric clashes between the bound substrate and active
site amino acids.
Each complex was modelled using the AMBER parm14SB force field. Parameters
assigned to the nonstandard 5mC and 3mC nucleotides were supplemented with GAFF
parameters, and Restrained Electrostatic Potential (RESP) charges. For Fe(IV) and the
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iron-ligating residues, the Metal Center Parameter Builder(31) was used to assign RESP
charges, and bonding, angle, dihedral and non-bonding parameters based on
B3LYP/LANL2DZ (Fe(IV)) and B3LYP/6-31G(d,p) (H, C, N, and O) optimized
structures (Gaussian 09 revision D.01)(32) of the iron-binding site using the Seminario
method.(33) The complexes were neutralized with Na+ counter ions, and solvated in a
water box such that at least 10.0 Å of water exists between the DNA–protein complex
and water box boundary.
All minimization, heating, equilibration, and production steps were performed with the
GPU-accelerated PMEMD module available in AMBER 14 or AMBER 16.(34–36) For
each step, the particle mesh Ewald method was used to employ a 10.0 Å electrostatic
cutoff. To minimize each system, 1000 cycles of steepest descent (SD) and subsequent
1000 cycles of conjugate gradient (CG) minimization were first applied to the solvent
and Na+ counter ions, followed by the complex hydrogen atoms, and finally the complex
heavy/hydrogen atoms. For the final minimization step, the entire system was subjected
to 1000 cycles of SD minimization followed by 2000 cycles of CG minimization.
Subsequently, each system was heated to 310 K over 120 ps with a 25.0 kcal mol–1 Å–2
restraint placed on the solute using the Langevin thermostat with a time step of 1 fs
under NVT conditions. The 25.0 kcal mol–1 Å–2 restraint was reduced to 0.0 kcal mol–
1

Å–2 over 100 ps under constant temperature and pressure conditions (Berendsen

barostat) using a 2 fs time step and SHAKE to constrain bonds involving hydrogen,
which was followed by 1 ns of unrestrained equilibration. Several pre-production
simulations were performed for each system to ensure adequate sampling and
accommodation of each substrate within the active site of ALKBH2 or AlkB.
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Representative structures (clustering methodology below) were chosen from these preproduction simulations to initiate the final 100 ns production simulations. Coordinates
were saved from each simulation every 5 ps and analyzed over the same interval.
The CPPTRAJ(37) module was utilized for analysis of each trajectory. The occupancy
of hydrogen bonds is reported for the duration of the simulation that the heavy atom
distance is < 3.4 Å and the hydrogen-bonding angle is > 120°. To examine the
placement of water within the active site, a three dimensional 20 Å3 grid centered on
the bound substrate was generated. Dark red spheres are shown on representative
structures and reflect an oxygen atom of a water molecule located in a 0.25 Å3 grid
space for at least 40% of the simulation. The pre-production and production trajectories
were clustered according to the positions of key active site residues (bound substrate,
W69, H131, D135 and E136 for AlkB, and bound substrate, F124, H171, D174 and
E175 for ALKBH2). A hierarchical agglomerative clustering methodology was used to
obtain a 3.0 Å minimum cutoff between clusters or four clusters were obtained. While
the representative structures are static snapshots, we report key structural parameters
over the entire trajectory to ensure that conclusions are representative of each simulation
trajectory. All distances are reported in Å and all angles are reported in degrees.
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RESULTS AND DISCUSSION
A 16mer DNA oligonucleotide (5’-GAAGACCTXGGCGTCC-3’, X = 5mC)
containing 5mC in a CpG dinucleotide context was prepared through solid phase DNA
synthesis with the phosphoramidite of 5mC.(23–26) High resolution electrospray
ionization time-of-flight (ESI-TOF) MS analysis of the oligonucleotide exhibited an
m/z of 1625.281 at its -3 charge state, which is in good agreement with the theoretical
m/z 1625.281 expected of the product oligonucleotide (Figure 2a and Table S1). In the
same -3 charge envelope, we also observed the ions of 5mC + Na+ (1632.608) and 5mC
+ K+ (1637.928). The observed m/z values of these species are consistent with the
corresponding calculated m/z values (Table S1).
Previously, our lab has purified the three AlkB family enzymes mentioned above and
tested their repair efficiency for 3mC, 1mA, 3mT, and 1mG in both ss- and ds-DNA.(23,
24) Similar procedures were adopted for the modification reactions of 5mC. The
reaction conditions and the oligonucleotide-enzyme ratios are similar to those observed
in the conversion of 5mC to its oxidative derivatives by the TET proteins reported in
the literature.(6–8) For each enzyme, experiments were conducted in triplicate both in
the presence and absence of the enzyme with all necessary cofactors at 37°C under both
ds- and ss-DNA conditions, and the reaction products were analyzed by high resolution
MS to ensure the differentiation of reaction products that have very similar m/z
values.(24)
First, we tried to identify the new oxidative products that appeared after the enzymatic
reactions. The three oxidative products, 5hmC, 5fC, and 5caC, all formed in the
reactions with all three enzymes, but every enzyme had a preference to generate a
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certain oxidative derivative. Below we use typical examples to demonstrate the
formation of a certain product. The MS results of ALKBH2 oxidizing 5mC in ds-DNA
(Figure 2b) showed a new oligonucleotide species that has an m/z for the monoisotopic
peak at 1630.615 at -3 charge state, which corresponds well to the theoretical m/z value
of the 16mer oligonucleotide containing 5hmC (1630.612 calculated, Table S1). In the
reaction of 5mC with ALKBH3 in ss-DNA, another oligonucleotide envelope appeared
at m/z 1629.951 (Figure 2c), which agrees with the 5fC base in the 16mer
oligonucleotide (1629.940 calculated). For the oxidation of 5mC by the AlkB protein in
ss-DNA, we observed the peak envelopes of 5hmC (1630.603), 5fC (1629.933) together
with a new species with an m/z value of 1642.604, which is close to the 16mer
oligonucleotide containing the sodium salt of 5caC (1642.600 calculated, Figure 2d and
Table S1). Other oligonucleotide species containing metal ions, such as Na+ and K+,
were also observed. The complete assignments of the major species generated from MS
analyses are summarized in Figure S1 and Table S1.
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Figure 2. High resolution ESI-TOF MS analyses of 16mer DNA oligonucleotides
containing 5mC and oxidized products. The observed m/z values represent the
oligonucleotides under their -3 charge state. a) 5mC; b) 5mC (in ds-DNA) + ALKBH2;
c) 5mC (in ss-DNA) + ALKBH3; and d) 5mC (in ss-DNA) + AlkB.

The product oligonucleotides were digested into single nucleosides, analyzed by LCMS, and compared with standard nucleosides to confirm the oxidative products
generated from enzymatic reactions are indeed 5hmC, 5fC, and 5caC (see the Product
oligonucleotides analyses section in SI, Figure S2 to S10). Also, to make sure the
oxidations were carried out by AlkB and its homologs, we generated the catalytically
inactive protein variants of AlkB: H131A, D133A, and H187A (Figure S11). The three
substituted amino acids in AlkB are the key residues that coordinate the Fe(II) ion.(13,
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38) The sequences of wild type and variant proteins were confirmed by trypsin digestion
with MS analyses (Figure S11 and Table S2). None of the AlkB variants showed any
detectable oxidative product when reacted with 5mC (Figure S12); these observations
suggest that the oxidative modifications were carried out by AlkB and not by a
contaminating enzyme.
For the oxidation of 5mC, the formation of products 5hmC, 5fC, and 5caC had different
distribution patterns for the three enzymes; and the three enzymes had different
preferences for oxidation in ss- or ds-DNA reactions (Figure 3 and the Product
distribution for the oxidation of 5mC section in SI). The overall activities of the three
AlkB proteins on oxidizing 5mC are similar to the proficiencies of the TET enzymes on
modifying 5mC reported in the literature(6–8) and are generally consistent with
theoretical calculations that report higher barriers for each successive oxidation steps by
TET2.(39) The conversion of 5mC to the corresponding oxidative intermediates by the
AlkB proteins were comparable to their repair of other known substrates (Modifications
on different alkyl substrates by the AlkB enzymes section in SI). In all of the enzymatic
reactions, we only observed the oxidation of 5mC, but not the thymine DNA base, which
naturally has a 5-methyl group. The same finding was reported for the TET family
enzymes.(8)
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Figure 3. Product distribution and strand preference (in univariate scatterplot) for the
oxidation of 5mC by the AlkB family enzymes. Reaction products (5hmC, 5fC and 5caC)
generated from the reactions of 5mC with the AlkB family enzymes in a) ds-DNA and
b) ss-DNA. c) Total product percentage from reactions of the AlkB family enzymes
oxidizing 5mC in ds- and ss-DNA.
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To probe the molecular basis by which the AlkB enzymes are able to oxidize 5mC, we
performed molecular dynamics (MD) simulations to examine how 5mC is
accommodated in the active sites of ALKBH2 and AlkB (Figure 4). We found that the
5-methyl of anti-5mC in our model is far from the Fe(IV)–oxo moiety (~5.3 Å for
ALKBH2 in Figure 4a and ~7.9 Å for AlkB in Figure 4d; also in Figures S13-S14, and
Tables S3-S6). In contrast, the distances between the Fe(IV)–oxo moiety and the 5methyl group in the models with syn-5mC bound to ALKBH2 or AlkB are much shorter
(~3.8 Å for ALKBH2 in Figure 4b and ~3.6 Å for AlkB in Figure 4e) and similar to the
distances in the structures of ALKBH2 or AlkB bound to their prototypic substrate 3mC
in the anti-conformation (~3.3 Å for ALKBH2 in Figure 4c and ~3.3 Å for AlkB in
Figure 4f.; See also the Simulations of ALKBH2 and AlkB bound to 3mC, 5hmC, and
5fC section in SI). With syn-5mC bound to ALKBH2 and AlkB, hydrogen bonds appear
possible between the N4 amino group of 5mC and active site residues. Specifically, syn5mC interacts with Asp and Glu residues (D174/E175 for ALKBH2, and D135/E136
for AlkB) through water (Tables S3-S4 and Figures S13-S14), as well as the Y122
hydroxy group in ALKBH2 (Table S3). These interactions likely facilitate oxidative
catalysis by positioning the C5 methyl group near the Fe(IV)–oxo moiety (~3.6 – 3.8 Å;
Tables S5-S6).
Interestingly, a crystal structure of TET2 co-crystallized with 5mC-containing DNA
reveals syn-5mC in the active site,(40) and the reported χ torsion angle is consistent with
that predicted for syn-5mC in ALKBH2/AlkB (Figure S15 and Tables S5-S6). Based
on our combined experimental and theoretical data, we propose that the AlkB family
enzymes are able to oxidize 5mC bound only in the syn-conformation.
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Figure 4. Representative molecular dynamics structures of the ALKBH2 (a-c) or AlkB
(d-f) complex bound to anti-5mC (a,d), syn-5mC (b,e), or anti-3mC (c,f). The distance
between the oxo-moiety and methyl groups is highlighted with dashed lines.
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To provide insight into the variable activities of ALKBH2 and AlkB for subsequent
nucleobase oxidation (Figure 3), MD simulations were performed on syn-5hmC and 5fC
bound in the active sites. For 5hmC, the C5 substituent is further from the Fe(IV)–oxo
moiety for ALKBH2 (~4.5 Å, Figure S16 and Tables S5) compared to AlkB (3.4 Å,
Figure S17 and Tables S6), which is consistent with the relative low abundance of the
5fC product for ALKBH2 (Figures 3, S19 to S21 and Tables S3 to S6). For 5fC,
increased flexibility of the bound nucleobase may permit enhanced catalysis and
generate more 5caC for ALKBH2 comparing to AlkB (Figures 3a, 3b, and S22). In
addition to the insights provided by the MD simulations (see SI for detailed discussions
of these calculations), several other factors could influence the product distributions
including DNA binding, oxidative reactivity and different base flipping mechanisms
used by each enzyme.
In this paper, we demonstrated the in vitro oxidative modification of 5mC to 5hmC, 5fC,
and 5caC by the three AlkB DNA repair enzymes. Thus, the AlkB proteins are not only
able to repair DNA adducts, such as 3mC and 3mT, but also can edit the epigenetic
modification 5mC and generate the corresponding oxidative derivatives. These
observations suggest a possible connection between DNA repair and epigenetic gene
modulation. Future investigation includes analyzing the kinetic parameters of the three
AlkB enzymes acting on 5mC, confirming the oxidation of 5mC by the AlkB enzymes
in cell, and probing whether other α-KG/Fe(II)-dependent dioxygenases can oxidize
5mC.
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TABLE AND FIGURES LEGENDS
Figure 1. Reaction pathway of the AlkB family DNA repair enzymes modifying 5mC
and 3mC.
Figure 2. High resolution ESI-TOF MS analyses of 16mer DNA oligonucleotides
containing 5mC and oxidized products. The observed m/z values represent the
oligonucleotides under their -3 charge state. a) 5mC; b) 5mC (in ds-DNA) + ALKBH2;
c) 5mC (in ss-DNA) + ALKBH3; and d) 5mC (in ss-DNA) + AlkB.
Figure 3. Product distribution and strand preference (in univariate scatterplot) for the
oxidation of 5mC by the AlkB family enzymes. Reaction products (5hmC, 5fC and 5caC)
generated from the reactions of 5mC with the AlkB family enzymes in a) ds-DNA and
b) ss-DNA. c) Total product percentage from reactions of the AlkB family enzymes
oxidizing 5mC in ds- and ss-DNA.
Figure 4. Representative molecular dynamics structures of the ALKBH2 (a-c) or AlkB
(d-f) complex bound to anti-5mC (a,d), syn-5mC (b,e), or anti-3mC (c,f). The distance
between the oxo-moiety and methyl groups is highlighted with dashed lines.
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Figure S7. MS analysis of standard 5fC deoxyribonucleoside under negative ion mode.
Figure

S8.

MS

analysis

of

digested

oligonucleotide

containing

5fC

deoxyribonucleoside under negative ion mode.
Figure S9. MS analysis of standard 5caC deoxyribonucleoside under negative ion mode.
Figure

S10.

MS

analysis

of

digested

deoxyribonucleoside under negative ion mode.

115

oligonucleotide

containing

5caC

Figure S11. MS analyses of trypsin digested proteins including the wild type and variant
AlkB enzymes.
Figure S12. ESI-TOF analyses of standard oligonucleotide containing 5mC and
reaction mixtures with wild type and variant proteins.
Figure S13. Distribution of active site water (red spheres) during MD simulations of
ALKBH2 bound to 5mC.
Figure S14. Distribution of active site water (red spheres) during MD simulations of
AlkB bound to 5mC.
Figure S15. Overlay of the 5mC nucleotide isolated from MD representative structures
of AlkB–5mC and ALKBH2–5mC complexes onto a crystal structure of TET2 bound
to 5mC-containing DNA.
Figure S16. Distribution of active site water during MD simulations of ALKBH2 bound
to anti-3mC and overlay of MD representative structures of ALKBH2 bound to syn5mC and anti-3mC.
Figure S17. Distribution of active site water during MD simulations of AlkB bound to
anti-3mC and overlay of MD representative structures of AlkB bound to syn-5mC and
anti-3mC.
Figure S18. Structures and chemical numbering of 3mC and 5mC.
Figure S19. Structures and chemical numbering of anti-3mC, syn-5mC, syn-5hmC, and
syn-5fC.
Figure S20. Distribution of active site water during MD simulations of ALKBH2 bound
to syn-5hmC, ALKBH2 bound to syn-5fC, AlkB bound to syn-5hmC, or AlkB bound to
syn-5fC.
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Figure S21. Simulations of ALKBH2 or AlkB bound to 5hmC.
Figure S22. syn-5fC Bound by ALKBH2 or AlkB, highlighting the distance between
the C5 substituent and the Fe(IV)-oxo moiety.
Figure S23. Different alkyl DNA modifications oxidized by the three AlkB family
enzymes at various time points.

Table S1. Calculated and observed monoisotopic molecular weight and m/z value of
modified oligonucleotides.
Table S2. Calculated and observed monoisotopic molecular weight and m/z value of
peptide fragments digested by trypsin.
Table S3. Summary of important hydrogen bonds formed during MD simulations of
anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the ALKBH2 complex.
Table S4. Summary of important hydrogen bonds formed during MD simulations of
anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the AlkB complex.
Table S5. Summary of important distances and dihedral angles adopted during MD
simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the ALKBH2
complex.
Table S6. Summary of important distances and dihedral angles adopted during MD
simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the AlkB
complex.
Table S7. Time to half maximum conversion (T1/2, min) for the oxidation of different
alkyl DNA modifications by the three AlkB family enzymes.
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Product oligonucleotides analyses
It was important to assure that the observed new oligonucleotide species indeed contain
the proposed oxidative products. The product oligonucleotides were digested with
benzonase into single nucleosides, which were analyzed by LC-MS and compared with
standard nucleosides for retention time and molecular weight. In the digestion of the
product generated from the AlkB reaction, a nucleoside was eluted out at 7.3 min in
HPLC (Figure S2) and had an observed m/z 240.2386 in the negative mode of MS
analysis (theoretical m/z 240.2392, Figure S4); these data agree well with the analysis
of the standard sample of 5mC nucleoside (7.3 min in HPLC and 240.2385 in m/z,
Figure S3). Another nucleoside from digestion had a retention time at 4.9 min in HPLC
(Figure S2) and had an m/z 256.2387 in the MS analysis (Figure S6); these data are
comparable to the standard sample of 5hmC nucleoside (5.0 min in HPLC and 256.2409
in m/z, theoretical m/z 256.2382, Figures S2 and S5). Similarly, nucleosides 5fC and
5caC were also discovered in the mixture of the digested reaction product and their
identities were confirmed by comparing to standard nucleosides (Figures S2, S7 to S10).
These observations support that the oxidative products generated from enzymatic
reactions are indeed 5hmC, 5fC, and 5caC.

Product distribution for the oxidation of 5mC
For the oxidation of 5mC, the formation of products 5hmC, 5fC, and 5caC had different
distribution patterns for the three enzymes; and the three enzymes had different
preferences of oxidation in ss- or ds-DNA reactions (Figure 3). The relative amount of
each product in the final reaction mixture was quantified according to the abundance of
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its corresponding ion at -3 charge state in the MS analysis. The product oligonucleotides
containing 5hmC was the dominant species for the reactions of ALKBH2 and 3 in both
ds- and ss-DNA (Figures 3a and 3b). For example, 5hmC represents 78.7% of the total
amount of the three oxidative products in the reaction of ALKBH2 with 5mC in dsDNA; 5fC and 5caC are quantified as 10.9% and 10.4% correspondingly (Figure 3a).
For the oxidation of 5mC by AlkB, 5hmC is the major species (51.2%) in ds-DNA
reaction; however, 5fC is the most abundant species (65.3%) in ss-DNA reaction
(Figures 3a and 3b). We were also able to quantify the yield of the oxidative products
by comparing them to the total oligonucleotide species. The ratios of the oxidative
products show ALKBH2 prefers to oxidize 5mC in ds-DNA (8.7%) over in ss-DNA
(5.5%), and ALKBH3 prefers to modify 5mC in ss-DNA (22.1%) over in ds-DNA
(4.2%) (Figure 3c). These results support the strand preference in repair reactions of
ALKBH2 (preferring ds-DNA) and ALKBH3 (preferring ss-DNA) reported in the
literature.(1) For AlkB, the enzyme oxidized 5mC in ss-DNA (23.5%) more efficiently
than in ds-DNA (13.3%) (Figure 3c); these results are similar to the preference of AlkB
repairing 3mC in ss-DNA.(2)

Modifications on different alkyl substrates by the AlkB enzymes
We compared the conversion efficiency of 5mC by the three AlkB family enzymes to
other known methyl substrates of the AlkB proteins. Those substrates include 3mC,
1mA, 3mT, and 1mG; and all of them have been demonstrated to be repaired by AlkB
both in vitro and in vivo.(1, 3) The results show the conversion of 5mC to the
corresponding oxidative products are comparable to the demethylation of 3mT and
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1mG; and the reactions of these three methyl modifications are slower than 3mC and
1mA (Figure S23 and Table S7). For example, T1/2 of the reactions for 5mC (16.9 min)
is slightly shorter than 3mT (17.4 min) but longer than 1mG (1.7 min) in the AlkB
reactions. For the ALKBH2 reactions, T1/2 for 5mC are comparable to 3mT and 1mG
(all between 16.4 to 18.7 min). For the ALKBH3 protein, 5mC is oxidized faster than
3mT and 1mG with about 5 minutes shorter in T1/2 than the other two (Figure S23 and
Table S7). Those biochemical results may indicate similar modification could happen
in cell: the modification of 5mC is comparable to the weaker AlkB substrates 3mT and
1mG but less efficiently than the stronger substrates 3mC and 1mA.(3)

Simulations of AlkBH2 and AlkB bound to 3mC, 5mC, 5hmC, and 5fC
To validate that the simulated structures of the ALKBH2 or AlkB complexes are
consistent with the observed catalytic activity, we examined the active site
conformations adopted upon binding of both enzymes to anti-3mC-, syn-5mC-, syn5hmC-, or syn-5fC-containing DNA. Similar DNA–protein interactions form when
3mC and 5mC are bound. Specifically, the 3mC N4 amino group forms direct hydrogen
bonds with the D174 or E175 sidechains when bound to ALKBH2 (Figure S16b and
Table S3), and direct or water-mediated hydrogen bonds with D135 and E136 when
bound to AlkB (Table S4 and Figure S17). As a result, the N3 methyl group of 3mC
occupies an equivalent active site position as the C5 methyl group of 5mC for both
enzymes (Figures S16b and S17b), with a distance between the Fe(IV)–oxo and the
3mC methyl moiety of ~ 3.3 Å for both enzymes (Tables S5-S6), and the syn-5mC
moiety of ~3.6 Å for AlkB and 3.8 Å for ALKBH2. Thus, the simulation data is
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consistent with the proposal that the AlkB family of enzymes is able to oxidize 5mC in
the syn orientation.
Similar to ALKBH2 or AlkB bound to 5mC, syn-5hmC is stabilized by direct or watermediated hydrogen bonds between the N4 amino group of the nucleobase and the
carboxylate moieties of D174 and E175 (D135 and E136 in AlkB; Tables S3-S4 and
Figure S20). For 5hmC bound by ALKBH2 or AlkB, hydrogen bonds are formed
between the C5 substituent hydroxy group and the Fe(IV)-oxo moiety (occupancy =
34% for ALKBH2 and 52% for AlkB; Tables S3-S4 and Figure S21). In ALKBH2, an
additional hydrogen bond is formed between the C5 substituent hydroxy group and
D173 (59%, Table S3), which results in one orientation of the C5 substituent throughout
the simulation (Figure S21a). In contrast, the C5 substituent hydroxy group does not
interact with D133 in AlkB, which results in two conformations of 5hmC within the
active site (Figure S21b-d). More importantly, the C5 substituent is at an optimum
distance from the Fe(IV)-oxo moiety in AlkB (~3.4 Å), which matches the prototypic
substrate (3mC; ~3.3 Å), while the equivalent distance is longer in the ALKBH2–5hmC
complex (~4.5 Å; Tables S5-S6 and Figure 3), which would impede catalysis. This helps
explain the observed higher abundance of 5fC for AlkB compared to ALKBH2
catalyzed oxidation on 5hmC, although several other factors could also be significant
such as DNA binding and unique base flipping mechanism for each enzyme.
As discussed for 5mC and 5hmC, the syn-conformation of 5fC is stabilized by
hydrogen bonds between the N4 amino group of the nucleobase and carboxylate
sidechains of active site residues (Tables S3-S4 and Figure S20). When bound to either
ALKBH2 or AlkB, 5fC is planar due to an intramolecular hydrogen bond between the
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N4 amino group and the carbonyl of the C5 substituent. A hydrogen bond also forms
between the carbonyl of the C5 substituent and an active site arginine, which is notably
more persistent for AlkB (R210, occupancy = 100.0%) than ALKBH2 (R254,
occupancy = 29.2%, Tables S3-S4 and Figure S20). As a result, the distance between
the hydrogen atom of the C5 substituent and the Fe(IV)-oxo group is longer for AlkB
(~3.8 Å) compared to ALKBH2 (3.3 Å; Tables S5-S6 and Figure S22). Although the
difference in distance for 5fC bound by ALKBH2 and AlkB is not as significant as
observed for 5hmC, QM/MM studies on TET2-catalyzed oxidation of 5mC, 5hmC, and
5fC reveal that the initial hydrogen atom abstraction step is rate limiting, with the barrier
increasing as 5mC < 5hmC < 5fC.(4) This suggests that the position of the substituent
relative to the Fe(IV)-oxo group is even more crucial in the case of 5fC. Thus, our
predicted structures correlate with the lower abundance of 5caC relative to 5fC for AlkB
compared to ALKBH2 (Figure 3). Nevertheless, as discussed for 5hmC, nucleotide
recognition and the base flipping mechanism could also play different roles in oxidative
conversion of 5fC to 5caC.
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Figure S1. ESI-TOF analyses of standard oligonucleotide containing 5mC and reaction
mixtures. The observed m/z values represent the oligonucleotides under their -3 charge
state. The theoretical m/z values of the corresponding species are listed in Table S1.
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Figure S2. HPLC analyses of deoxyribonucleoside standards and benzonase digested
product oligonucleotides.
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Figure S3. MS analysis of standard 5mC deoxyribonucleoside under negative ion mode.
The theoretical m/z value of the corresponding species is listed next to the observed
peak.
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Figure

S4.

MS

analysis

of

digested

oligonucleotide

containing

5mC

deoxyribonucleoside under negative ion mode. The theoretical m/z value of the
corresponding species is listed next to the observed peak.
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Figure S5. MS analysis of standard 5hmC deoxyribonucleoside under negative ion
mode. The theoretical m/z value of the corresponding species is listed next to the
observed peak.
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Figure

S6.

MS

analysis

of

digested

oligonucleotide

containing

5hmC

deoxyribonucleoside under negative ion mode. The theoretical m/z value of the
corresponding species is listed next to the observed peak.
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Figure S7. MS analysis of standard 5fC deoxyribonucleoside under negative ion mode.
The theoretical m/z value of the corresponding species is listed next to the observed
peak.
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Figure

S8.

MS

analysis

of

digested

oligonucleotide

containing

5fC

deoxyribonucleoside under negative ion mode. The theoretical m/z value of the
corresponding species is listed next to the observed peak.

130

Figure S9. MS analysis of standard 5caC deoxyribonucleoside under negative ion mode.
The theoretical m/z value of the corresponding species is listed next to the observed
peak.
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Figure

S10.

MS

analysis

of

digested

oligonucleotide

containing

5caC

deoxyribonucleoside under negative ion mode. The theoretical m/z value of the
corresponding species is listed next to the observed peak.
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Figure S11. MS analyses of trypsin digested proteins including the wild type and variant
AlkB enzymes.
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Figure S12. ESI-TOF analyses of standard oligonucleotide containing 5mC and
reaction mixtures with wild type and variant proteins. The observed m/z values
represent the oligonucleotides under their -3 charge state. The theoretical m/z values of
the corresponding species are listed in Table S1.
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Figure S13. Distribution of active site water (red spheres) during MD simulations of
ALKBH2 bound to a) anti-5mC or b) syn-5mC. c) ALKBH2 bound to syn-5mC
highlighting key hydrogen-bonding interactions. d) Overlay of MD representative
structures of ALKBH2 bound to anti- (blue) or syn- (gray) 5mC.
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Figure S14. Distribution of active site water (red spheres) during MD simulations of
AlkB bound to a) anti-5mC or b) syn-5mC. c) AlkB bound to syn-5mC highlighting key
water mediated hydrogen-bonding interactions.

d) Overlay of MD representative

structures of AlkB bound to anti- (cyan) or syn- (blue) 5mC.
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Figure S15. Overlay of the 5mC nucleotide isolated from MD representative structures
of AlkB–5mC (blue) and ALKBH2–5mC (gray) complexes onto a crystal structure of
TET2 bound to 5mC-containing DNA, Fe(II), and α-KG (teal; PDB ID: 4NM6),(5)
highlighting the similarity in the 5mC glycosidic bond conformation (χ).
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Figure S16. Distribution of active site water during MD simulations of ALKBH2 bound
to anti-3mC and overlay of MD representative structures of ALKBH2 bound to syn5mC and anti-3mC. a) Distribution of active site water (red spheres) during MD
simulations of ALKBH2 bound to anti-3mC. b) ALKBH2 bound to anti-3mC,
highlighting key hydrogen-bonding interactions. c) Overlay of MD representative
structures of ALKBH2 bound to syn-5mC (gray) and anti-3mC (blue).
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Figure S17. Distribution of active site water during MD simulations of AlkB bound to
anti-3mC and overlay of MD representative structures of AlkB bound to syn-5mC and
anti-3mC. a) Distribution of active site water (red spheres) during MD simulations of
AlkB bound to anti-3mC. b) AlkB bound to anti-3mC, highlighting key water mediated
hydrogen-bonding interactions. c) Overlay of MD representative structures of AlkB
bound to syn-5mC (blue) and anti-3mC (cyan).
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Figure S18. Structures and chemical numbering of a) 3mC and b) 5mC. The glycosidic
bond orientation is defined by dihedral angle χ (blue, ∠O4′C1′N1C2) as either anti (left,
180 ± 90°) or syn (right, 0 ± 90°).

Figure S19. Structures and chemical numbering of a) anti-3mC, b) syn-5mC, c) syn5hmC, and d) syn-5fC. The glycosidic bond orientation is defined by the χ dihedral
angle (blue, ∠(O4′C1′N1C2)) as anti (180 ± 90°) or syn (0 ± 90°).
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Figure S20. Distribution of active site water (red spheres) during MD simulations of a)
ALKBH2 bound to syn-5hmC, b) ALKBH2 bound to syn-5fC, c) AlkB bound to syn5hmC, or d) AlkB bound to syn-5fC. Key hydrogen-bonding interactions are
highlighted with dashed lines.
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Figure S21. Simulations of ALKBH2 or AlkB bound to 5hmC. a) ALKBH2 bound to
syn-5hmC, and AlkB bound to syn-5hmC with b) θ (∠(C4C5C7O7)) ~ –132° and c) θ
~ 50°, highlighting different orientations of the C5 substituent. d) Histogram displaying
the occupancy of θ (degree) during simulations of ALKBH2 or AlkB bound to 5hmC.
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Figure S22. syn-5fC Bound by a) ALKBH2 or b) AlkB, highlighting the distance
between the C5 substituent and the Fe(IV)-oxo moiety.
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Figure S23. Different alkyl DNA modifications oxidized by the three AlkB family
enzymes at various time points. Top: AlkB; middle: ALKBH2; and bottom: ALKBH3.
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Table S1. Calculated and observed monoisotopic molecular weight and m/z value of
modified

oligonucleotides.

The

sequence

of

the

16mer

was

5’-

GAAGACCTXGGCGTCC-3’, where X indicates the position of 5mC or oxidized bases.
MW
(calculated)
of neutral
species

m/z
(calculated)
-3 charge
peak

5mC
control

ALKBH2

ALKBH3

AlkB

5mC

4878.866

1625.281

1625.281

1625.279

1625.285

1625.276

5mC + Na+

4900.848

1632.608

1632.608

1632.616

1632.613

1632.608

5mC + K+

4916.822

1637.933

1637.928

1637.941

1637.942

1637.931

5mC + 2Na+

4922.830

1639.935

1639.941

1639.937

1639.938

1639.931

5mC + Na+ + K+

4938.803

1645.260

1645.267

1645.273

1645.261

1645.263

5hmC

4894.861

1630.612

-

1630.615

1630.607

1630.603

5hmC + Na+

4916.843

1637.940

-

1637.941

1637.942

1637.931

5hmC + K+

4932.816

1643.264

-

1643.265

1643.259

1643.262

5fC

4892.845

1629.940

-

1629.936

1629.951

1629.933

5fC + Na+

4914.827

1637.268

-

1637.288

1637.285

1637.257

5fC + 2Na+

4936.809

1644.595

-

1644.605

1644.588

1644.598

5caC + Na+

4930.814

1642.600

-

1642.616

1642.611

1642.604

modification

m/z (observed) -3 charge peak
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Table S2. Calculated and observed monoisotopic molecular weight and m/z value of
peptide fragments digested by trypsin.
MW

m/z

peptide

(calculated)

(calculated)

sequence

of neutral

+1 charge

species

peak

LSLHQDK

839.450

LSLHQAK

m/z (observed) +1 charge peak

AlkB

AlkB

AlkB

AlkB

wt

D133A

H131A

H187A

840.457

840.470

-

-

840.470

795.460

796.468

-

796.480

-

-

LSLAQDK

773.428

774.436

-

-

774.449

-

LFYHGIQPLK

1214.681

1215.688

1215.706

1215.706

1215.706

-

LFYAGIQPLK

1148.659

1149.667

-

-

-

1149.681
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147
2.8 (152)
3.1 (132)
N/A
N/A

D174(Oδ)···H2O(OH)

mC(O5)···R254(NηH)

Fe(IV)-oxo(O)···mC(O5H)

D173(Oδ)···mC(O5H)
N/A

N/A

29.20%

>100.0%

>100.0%

0.00%

41.90%

0.90%

56.10%

0.00%

26.20%

0.00%

100.00%

%a,b

2.7 (152)

2.9 (144)

3.1 (140)

2.8 (157)

2.7 (162)

3.1 (129)

2.9 (163)

3.0 (146)

2.8 (150)

3.1 (151)

3.1 (141)

2.9 (164)

2.9 (151)

Dist
(Angle)c,d

58.50%

33.90%

37.00%

>100.0%

>100.0%

10.20%

100.00%

30.00%

>100.0%

>100.0%

5.00%

32.00%

83.20%

%a,b

syn-5hmC

N/A

N/A

N/A
N/A

N/A

>100%

>100%

17.70%

78.70%

62.50%

94.30%

72.20%

90.00%

0.00%

0.30%

%a,b

N/A

2.8 (160)

2.7 (160)

3.2 (129)

2.8 (164)

3.1 (147)

2.9 (154)

3.1 (137)

3.0 (146)

N/A

3.0 (145)

Dist
(Angle)c,d

syn-5mC

N/A

N/A

N/A

2.8 (157)

2.8 (159)

3.0 (151)

2.8 (163)

3.0 (154)

3.1 (143)

3.1 (146)

3.1 (145)

N/A

N/A

Dist
(Angle)c,d

N/A

N/A

N/A

>100%

>100%

>100%

0.20%

57.60%

4.80%

78.90%

15.90%

0.00%

0.00%

%a,b

anti-5mC

N/A

N/A

N/A

2.8 (158)

N/A

N/A

2.7 (165)

N/A

3.2 (128)

3.1 (138)

N/A

2.8 (166)

2.8 (159)

Dist
(Angle)c,d

3mC

N/A

N/A

N/A

>100%

0.00%

0.00%

99.00%

0.00%

0.10%

55.30%

0.00%

94.30%

99.10%

%a,b

occupancy of the hydrogen bond, which is defined using cutoffs of a distance less than 3.4 Å and an angle greater than 120°. bGreater than 100% occupancy
indicates the presence of more than one water hydrogen bonding with an acceptor site. cHydrogen bonding distance in Å. dAngle in ° (in parentheses).

2.7 (159)

E175(Oε)···H2O(OH)

aPercent

N/A

H2O(O)···Y122(OH)

2.8 (151)

mC(O2)···H2O(OH)

2.9 (154)

3.2 (126)

H2O(O)···mC(N4H)

E175(Oδ)···Y122(OH)

3.1 (136)

Y122(OH)···mC(N4H)

3.2 (138)

N/A

D174(Oδ)···mC(N4H)

mC(N3)···H2O(OH)

2.9 (160)

E175(Oδ)···mC(N4H)

Dist
(Angle)c,d

syn-5fC

and syn-5fC in the ALKBH2 complex.

Table S3. Summary of important hydrogen bonds formed during MD simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC,
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2.8 (157)
2.8 (155)
N/A
N/A

D135(Oδ)···H2O(OH)

mC(O5)···R210(NηH)

Fe(IV)-oxo(O)···mC(O5H)

D133(Oδ)···mC(O5H)
N/A

N/A

100.00%

>100.0%

>100.0%

43.70%

96.30%

>100.0%

57.40%

>100.0%

0.20%

%a,b

N/A

2.8 (152)

2.9 (160)

2.8 (157)

2.8 (158)

3.1 (135)

2.7 (165)

3.0 (156)

3.0 (141)

3.1 (138)

3.2 (132)

Dist
(Angle)c,d

0.00%

51.70%

35.10%

>100.0%

97.80%

42.70%

65.70%

>100.0%

72.90%

>100.0%

1.60%

%a,b

syn-5hmC

N/A

N/A

N/A
N/A

N/A

>100%

>100%

5.60%

36.00%

95.50%

>100%

>100%

11.80%

%a,b

N/A

2.8 (157)

2.9 (152)

3.1 (145)

2.7 (162)

3.0 (152)

2.9 (152)

3.1 (145)

3.1 (143)

Dist
(Angle)c,d

syn-5mC

N/A

N/A

N/A

2.8 (158)

2.7 (160)

3.1 (137)

N/A

N/A

N/A

>100%

>100%

25.80%

58.50%

91.00%

2.9 (150)
2.7 (165)

>100%

>100%

0.60%

%a,b

2.9 (154)

3.1 (142)

3.2 (135)

Dist
(Angle)c,d

anti-5mC

N/A

N/A

N/A

2.8 (158)

2.8 (158)

3.1 (150)

2.6 (163)

N/A

3.0 (150)

3.1 (150)

2.9 (147)

Dist
(Angle)c,d

3mC

N/A

N/A

N/A

>100%

>100%

88.90%

62.30%

0.00%

32.90%

>100%

42.60%

%a,b

occupancy of the hydrogen bond, which is defined using cutoffs of a distance less than 3.4 Å and an angle greater than 120°. bGreater than 100% occupancy
indicates the presence of more than one water hydrogen bonding with an acceptor site. cHydrogen-bonding distance in Å. dAngle in ° (in parentheses).

2.7 (162)

E136(Oε)···H2O(OH)

aPercent

3.1 (141)

2.9 (155)

mC(N3)···H2O(OH)

H2O(O)···Y78(OH)

3.0 (143)

mC(O2)···H2O(OH)

2.7 (164)

3.1 (137)

H2O(O)···mC(N4H)

E136(Oδ)···Y78(OH)

3.2 (132)

D133(Oδ)···mC(N4H)

Dist
(Angle)c,d

syn-5fC

Table S4. Summary of important hydrogen bonds formed during MD simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC,
and syn-5fC in the AlkB complex.

Table S5. Summary of important distances and dihedral angles adopted during MD
simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the
ALKBH2 complex.

Fe(IV)–oxo···C(C7)a

3mC

anti-5mC

syn-5mC

syn-5hmC

syn-5fC

Avg (σ)

Avg (σ)

Avg (σ)

Avg (σ)

Avg (σ)

3.3 (0.2)

5.3 (0.5)

3.8 (0.3)

4.5 (0.8)

3.2 (0.4)

Fe(IV)–
3.2 (0.7)
5.5 (0.8)
3.6 (0.6)
4.7 (1.1)
3.3 (0.4)
oxo···C(H71)a
Fe(IV)–
3.2 (0.6)
5.5 (0.8)
3.6 (0.6)
6.9 (0.6)
N/A
oxo···C(H72)a
Fe(IV)–
3.2 (0.7)
5.5 (0.8)
3.6 (0.6)
3.2 (1.4)
N/A
oxo···C(H73)a
C(χ)b
–147 (15)
–143 (19)
49 (11)
-9 (17)
-19 (19)
a
b
Modification of either N3 (3mC; Figure S19) or C5 (5mC, 5hmC, or 5fC; Figure S19). χ of bound
pyrimidine defined as ∠(O4′C1′N1C2) (Figures S18 and S19).

Table S6. Summary of important distances and dihedral angles adopted during MD
simulations of anti-3mC, anti-5mC, syn-5mC, syn-5hmC, and syn-5fC in the AlkB
complex.
3mC

anti-5mC

syn-5mC

syn-5hmC

syn-5fC

Avg (σ)

Avg (σ)

Avg (σ)

Avg (σ)

Avg (σ)

Fe(IV)–oxo···C(C7)a

3.3 (0.2)

7.9 (2.0)

3.6 (0.4)

3.4 (0.2)

3.5 (0.4)

Fe(IV)–oxo···C(H71)a

3.5 (0.7)

8.2 (2.0)

3.6 (0.7)

3.3 (0.6)

3.8 (0.5)

Fe(IV)–oxo···C(H72)a

3.4 (0.7)

8.2 (2.0)

3.5 (0.7)

5.8 (0.4)

N/A

3 a

Fe(IV)–oxo···C(H7 )

3.4 (0.7)

8.2 (2.0)

3.6 (0.7)

3.3 (1.5)

N/A

C(χ)b

–128 (11)

–116 (13)

32 (17)

44 (18)

51 (10)

Modification of either N3 (3mC; Figure S19) or C5 (5mC, 5hmC, or 5fC; Figure S19). χ of bound
pyrimidine defined as ∠(O4′C1′N1C2) (Figures S18 and S19).
a

b
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Table S7. Time to half maximum conversion (T1/2, min) for the oxidation of different
alkyl DNA modifications by the three AlkB family enzymes.
1mA

3mC

5mC

3mT

1mG

AlkB

< 1.0

< 1.0

16.9

17.4

1.7

ALKBH2

< 1.0

< 1.0

17.2

18.7

16.4

ALKBH3

< 1.0

< 1.0

25.2

30.0

30.7
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ABSTRACT
Bulky organic carcinogens are activated in vivo and subsequently react with nucleobases
of cellular DNA to produce adducts. Some of these DNA adducts exist in multiple
conformations that are slowly interconverted to one another. Different conformations
have been implicated in different mutagenic and repair outcomes. However, studies on
the conformation-specific inhibition of replication, which is more relevant to cell
survival, are scarce, presumably due to the structural dynamics of DNA lesions at the
replication fork. It is difficult to capture the exact nature of replication inhibition by
existing end-point assays, which usually detect either the ensemble of consequences of
all the conformers or the culmination of all cellular behaviors, such as mutagenicity or
survival rate. We previously reported very unusual sequence-dependent conformational
heterogeneities involving FABP-modified DNA under different sequence contexts
(TG1*G2T [67%B:33%S] and TG1G2*T [100%B], G*, N-(2′-deoxyguanosin-8-yl)-4′fluoro-4-aminobiphenyl) (Cai et al. Nucleic Acids Research, 46, 6356-6370 (2018)). In
the present study, we attempted to correlate the in vitro inhibition of polymerase activity
to different conformations from the single FABP-modified DNA lesion. We utilized a
combination of surface plasmon resonance (SPR) and HPLC-based steady-state kinetics
to reveal the differences in terms of binding affinity and inhibition with polymerase
between these two conformers (67%B:33%S and 100%B).

155

KEYWORDS
4-aminobiphenyl; bulky DNA lesion, conformational heterogeneity, surface plasma
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INTRODUCTION
The human genome is under constant assault from the environment. DNA-damageinduced mutations are known to trigger chemical carcinogenesis [1-5]. Therefore,
understanding the biological responses of cells to DNA mutations is important.
Arylamines belong to a notorious group of environmental mutagens/carcinogens that
produce bulky DNA adducts in vivo [6-10]. They are known to adopt different unique
conformational motifs: the major groove B-type (B), stacked (S) (Figure 1a) [11], or the
minor groove wedge (W) [12]. Consequently, these bulky-lesion induced
conformational heterogeneities complicate mutational and repair outcomes [9-11, 1315].
4-Aminobiphenyl (ABP) is a major etiological agent of human bladder carcinogen
and a potent urinary-bladder carcinogen in experimental animals. As such, commercial
production of ABP is banned, however, exposure to ABP can still take place from
cigarette smoke. ABP is activated by cellular N-acetyltransferase to produce dG-C8substituted adduct as a major DNA lesion (dG-C8-ABP, Figure 1b) [12, 16-20]. The
majority of human bladder cancer has a mutation in the p53 gene. Compared with other
cancers, the ABP-induced mutations are more evenly distributed along the p53 gene and
the mutation hotspots occur at both CpG, such as codons 175, 248, and 273, and nonCpG sites, such as codons 280 and 285, the latter two being unique mutational hotspots
for bladder and other urinary tract cancers [21]. The major induced mutation was is G
to T transversion mutation. Translesion synthesis (TLS) over dG-C8-ABP in two
different sequences (CCG*GAGGC and CCGGAG*GCC, G*=dG-C8-ABP), which
represent codon 248 and 249 sequences of the human p53 tumor suppressor gene,
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respectively, has confirmed that codon 248 is both hot spot of ABP adduct formation
and G to T mutation [22]. These results suggest that the efficiency of TLS over dG-C8ABP is influenced by the surrounding DNA sequences. The structurally similar liver
carcinogens 2-aminofluorene (AF) and N-2-acetylaminofluorene (AAF) produce
similar C8-dG adducts. AF could be error-free by correctly base pairing with an
incoming dC, whereas AAF blocks the replication process and requires recruitment of
lesion bypass polymerases for TLS. In Escherichia coli, the TLS of AF produces point
and frameshift mutations, whereas bypass of the AAF lesion is frequently accompanied
by a frameshift mutation.

Figure 1. (a) Two major conformational views of dG-C8-FABP [N-(2′-deoxyguanosin8-yl)-4′-fluoro-4-aminobiphenyl]: B-, and S-conformers. FABP-red, modified dG-blue,
complementary C-orange. (b) The chemical structure of dG-C8-FABP.

Our previous structural studies showed that fully paired duplexes containing the
fluorine containing model dG-C8-FABP (fluorine-labeled ABP, FABP, N-(2′deoxyguanosin-8-yl)-4′-fluoro-4-aminobiphenyl) adopted a 67%:33% mixture of the Band S-conformers in the TG1*G2T (G*=FABP) sequence context at 25 °C [23].
Meanwhile, the same lesion in the TG1G2*T context exhibited exclusively the B-type
conformation under identical experimental condition. When a replication polymerase
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encounters a bulky DNA lesion, the polymerase is likely to stall thus stopping DNA
synthesis. The lesion also influences whether the DNA replication will be error-free or
error-prone. The aforementioned striking sequence effect in buffer systems warrants
systematic studies in the presence of a polymerase. Vaidyanathan et al. [24] probed the
sequence effect of dG-C8-AF (AF, aminofluorene), a structural analog of ABP, on
nucleotide insertion efficiencies catalyzed by the Klenow fragment (Kf-exo−) on TG*A
and CG*A sequences [25-26]. They found that the S conformer of CG*A
thermodynamically favors the insertion of mutagenic A over non-mutagenic C at the
lesion site. Xu et al. reported that Kf-exo− is a strong binder to template/primer junctions,
but with minimal nucleotide selectivity against modified DNA [27]. The sequencedependent conformational heterogeneity may play an important role in DNA replication
and mutation. We hypothesize that different conformations lead to different extents of
polymerase binding affinities, kinetic behaviors, and replication blocks, ultimately
resulting in complex toxic and mutational outcomes. Here we conducted surface
plasmon resonance (SPR) binding experiments and steady-state enzyme kinetics in vitro
to probe the effect of ABP-induced conformational heterogeneity on DNA replication.
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RESULTS
DNA Sequence Systems
For SPR binding experiments, we constructed two biotinylated hairpin-based template–
primer strands (Figure 2a), 85-mer G1* adduct and 84-mer G2* adduct (G* = dG-C8FABP). Specifically, two FABP-modified–biotin–31-mer DNA sequences (TG1*G2T
and TG1G2*T) were purified by HPLC and characterized individually by enzyme
digestion/MALDI-MS [27-30] (Figure S1). A 54-mer hairpin DNA was annealed and
ligated to the biotin–31-mer TG1*G2T oligonucleotide, whereas a 53-mer hairpin DNA
was ligated to the biotin–31-mer TG1G2*T oligonucleotide. The hairpin structures were
used to improve the thermal stability of the oligonucleotide duplex during SPR
experiments and the lesion G1* and G2* adduct were placed at the 21st and 22nd bases,
respectively, to avoid clash between the polymerase protein and the gold chip surface
[27, 31-32].
For HPLC-based steady-state kinetics experiments, two 16-mer G1* or G2* template
strands were each annealed to various lengths of complementary strands (8-mer to 11mer) to create n-3, n-2, n-1, and n for the G1* adduct and n-2, n-1, n, and n+1 for G2*
(n is the lesion site) (Figure 3a and 3b) [23, 33-35].
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Figure 2. (a) Hairpin template−primer oligonucleotide constructs of 85-mer G1 and 84mer G2 for Kf-exo−, H denotes 3’-dideoxy-nucleotide; (b) Sensorgrams of binary
complexes of Kf-exo− with 85-mer and 84-mer unmodified control, G1-FABP and G2FABP modified sequences (1:1 binding fitted curves are overlaid as black lines); (c) Ka
(Ka-modified / Ka-contol) and Kd (Kd-modified / Kd-contol) ratio, G1 and G2 represent
the ratio of 85-mer FABP-G1/85-mer-control and 84-mer FABP-G2/84-mer-control,
respectively.
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Figure 3. DNA replication models for (a) FABP-modified G1* (TG*GT) templates and
(b) FABP-modified G2* (TGG*T) templates. n: lesion site. Lineweaver–Burk model of
DNA synthesis catalyzed by Kf-exo− at (c) 10-mer, G1-FABP and (d) 9-mer G2-FABP
lesion sites with dCTP at steady-state. The G1-FABP against with Kf–exo– adopted a
competitive inhibitor model, whereas the behavior of TG1G2*T showed as noncompetitive (see text).
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Oligonucleotide Characterization by MALDI-TOF MS (Matrix-Assisted Laser
Desorption/ Ionization-Time of Flight Mass Spectrometry)
The

FABP-modified

biotin–31-mer

oligonucleotides

were

characterized

by

exonuclease enzyme digestion followed by MALDI-TOF MS analysis in accordance
with the published procedures [27, 36]. In the present case, 5′-3′ exonuclease digestion
on DNA was difficult to carry out due to the binding hindrance of 5’-biotin motif to the
enzyme. Figure S1b shows the MALDI-TOF MS spectra of the 3′-5′ snake venom
phosphodiesterase (SVP) exonuclease digestions of the biotin–31-mer G1* adduct at
different time points (0, 1, 4, 6, 7, 8, and 10 min). The m/z of 9,804 (theoretical 9,803)
at 0 min represents the control mass-to-charge ratio. Within 6 min of 3′-5′ exonuclease
digestion, the lower masses appeared corresponding to the 27-mer to 21-mer fragments.
The m/z = 6,788 (theoretical 6,787) fragment, which persisted from 6 min to 10 min
was assigned to the G1*-FABP-modified 21-mer. These results confirm the first eluting
peak (peak 1) from the HPLC profile (Figure S1a) is biotin–31-mer TG1*G2T. Figure
S1c presents the MALDI-TOF MS spectra of the peak 2 on HPLC with 3′-5′
exonuclease digestions. The digestions were fast in the first 4 min showing the m/z
range from 9,803 to 7,116. However, the digestion stalled from 4-10 min at m/z 7,116,
which corresponds to the 22-mer fragment containing the FABP-modified guanine
(theoretical m/z = 7,116). These results confirm that peak 2 is G2*-FABP-modified
biotin–31-mer.
The 84- and 85-mer biotinylated oligonucleotides were purified and identified by
15% denaturing polyacrylamide gel (Hercules, CA) [27]. Figure S2 reveals the
denaturing gel profiles of unmodified/modified 84- and 85-mer ligated oligonucleotides,
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biotin–31-mer, and 53-mer/54-mer non-ligated oligonucleotides. For the 85-mer control,
all the biotin–31-mer and 54-mer hairpins were ligated. As for the 84-mer control, 85mer G1*, and 84-mer G2*, excessive biotin–31-mer, 54-mer, and 53-mer were observed
correspondingly. The ligated and purified 85-mer control/ G1* and 84-mer control/ G2*
were used for SPR experiments.

HPLC-based Steady-state Kinetics
We conducted steady-state experiments to investigate the impact of conformational
heterogeneity on nucleotide insertion kinetics [37]. The E. coli exonuclease-deficient
Kf-exo− was used for single-nucleotide incorporation. Although the modified base could
pair with dCTP to complete the primer extension reaction induced by Kf-exo−, the
reaction efficiency was much poorer than the regular DNA template. The change of
efficiency is represented by the enzyme kinetic parameters, Km and kcat, and the results
are summarized in Table 1. The bulky C8 adduct on guanine does not directly block the
Watson-Crick base pairing, but it could either physically interfere with the dNTP
binding pocket in Kf-exo− when the FABP-G holds an “S” conformation; or distort Kfexo− structure in the ternary complexes and influence the geometry at the active site of
forming phosphodiester bonds when FABP-G holds the “B” conformation (Figure 1a).
In both scenarios, the bulky adduct acts as an inhibitor, but in two different ways (Figure
3). In order to apply the inhibition kinetic model, the whole primer extension assay was
performed by maintaining the concentration of inhibitor (FABP-containing DNA
duplex), and varying the concentration of substrate, dNTP (dCTP or dATP). dATP was
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added to 16/8-mer and 16/11-mer systems, whereas dCTP was added to 16/9-mer and
16/10-mer sequences (Figure 3).
dCTP Incorporation: Specifically, adding dCTP to the n-1 (16/10-mer) G1* adduct
elongated a single 11-mer (Figure 3a), whereas the n-1 (16-/9-mer) G2* adduct produced
10- and 11-mer (Figure 3b). The formation of 10- and 11-mer mixture from the G2*
adduct sequence was difficult to quantify; thus, the reduction of the starting material 9mer was employed to determine the kinetic parameters for both G1* and G2* reactions.
The n-1 (16/9-mer) G2* adduct shows a Km value (5.7 µM) similar to that of the
control (5.8 µM); such similarity indicates an almost equal affinity (Table 1). However,
the insertion efficiency fins of dCTP opposite –G2* is 4-fold lower than that of the
unmodified control (0.24 :1) (Table 1). By contrast, the Km of the G1* adduct shows a
lower affinity (23.4 µM) than that of the control (7.4 µM). The insertion efficiency fins
in G1* is three times lower than the control (0.33 to 1). These two forms of enzyme
inhibition can be clearly shown by the Lineweaver-Burk plot. As shown by the
Lineweaver–Burke enzyme inhibition model (Figure 3c), the (16/10-mer) G1* adduct
and its control intersect on the Y-axis and a competitive inhibition behavior is suggested.
By contrast, the n-1 16/9-mer G2* adduct and its control merge at the x-axis. This
behavior can be explained as non-competitive inhibition (Figure 3d). When the n-1
(16/9-mer) G2* adduct elongated to 10-mer (n) and 11-mer (n+1), few 10-mer primers,
but most of the 11-mer primers, were observed from the HPLC profile. This result was
achieved because the bulky FABP on the G2 at the lesion site (n) does not block the
replication from n-1 to n+1.
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Table 1. Steady-state kinetic parameters for insertion of dCTP opposite unmodified and
FABP−dG adduct with Kf-exo−
Sequence

Km (µM)

kcat (min-1)

kcat/Km (µM-1·min-1)

*

FABP-G1

23.4 ± 0.01

29.7 ± 0.63

1.27

0.33

Control-G1

7.4 ± 0.10

28.8 ± 0.96

3.87

1.00

FABP-G2

5.7 ± 0.01

5.5 ± 0.11

0.97

0.24

Control-G2

5.8 ± 0.11

23.2 ± 0.70

4.00

1.00

fins

*

fins= (kcat /Km)modified/(kcat /Km)unmodified control

dATP Incorporation: The long-range lesion effect was examined by initiating the
primer elongation with a 16/8-mer template/primer that produces n-2 for G2* (Figure
3b) and n-3 for G1* (Figure 3a). Figure S3a presents the results at 10 min. In the control,
~70% of the 8-mer was extended to 9-mer. With adduct on G1, ~40% of the 8-mer was
converted to 9-mer, indicating a moderate pre-lesion effect at G1*. However, G2*
blocked ~80% of the 8-mer converting to 9-mer, which indicates a much stronger prelesion effect than that of G1*. These results are not surprising because the 8-mer primer
is closer to the G2* adduct than the G1* adduct. In the 11-mer (Figure S3b), unmodified
control exhibited 90% of dATP insertion. However, only ~20% of the 11-mer was
elongated to 12-mer opposite the G1* lesion. This finding indicates a strong post-lesion
effect. Moreover, only ~55% of the 11-mer was converted to 12-mer in the n+1 for G2*.
These results suggest significant retardation of insertion close to the lesion site.

Kf-exo− SPR binding Kinetics
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Binary System—Figure 2b shows the sensorgrams for the binary binding between Kfexo− and unmodified controls (85-mer/84-mer TGGT) or modified sequences (85-mer
TG1*G2T/84-mer TG1G2*T). These sequences represent replication fork for the G1* and
G2*, respectively. Kf-exo− shows a much stronger binding affinity (KD) to the modified
85-mer TG1*G2T (8.3-fold) and 84-mer (5.6-fold) TG1G2*T sequences relative to their
unmodified controls, 85-mer and 84-mer TGGT, respectively (Table 2). The differences
are more striking in the dissociation rates (85-mer TGGT kd: 0.84 s−1 vs. 85-mer
TG1*G2T kd: 0.17 s−1; 84-mer TGGT kd: 0.03 s−1 vs. 84-mer TG1G2*T kd: 0.009 s−1).
There is a substantial difference in Kd ratio (Kd-modified/Kd-control) between G1 and
G2 (Figure 2c). By contrast, the Ka ratios of G1 and G2 are close to each other, indicating
similar association rates. The stabilization energies here specifically measure the
energies of forming hydrogen bonds between Kf-exo− and DNA sequences [38]. For the
binary system the net stabilization energies are positive (Table S1) which indicate the
hydrogen bonds that form between Kf-exo− and modified sequences (85-mer
TG1*G2T/84-mer TG1G2*T) are stronger than their unmodified controls (85-mer/84mer TGGT). It is interesting to note that although only one base length (dC) differed
between the 84-mer and 85-mer, the binding affinity of the unmodified 84-mer was
18.2-fold tighter than that of the 85-mer. Similarly, the KD of the 84-mer TG1G2*T is
12.2-fold greater than that of the 85-mer TG1*G2T.
Ternary System— dNTP was added to form Klenow ternary complexes. Kf-exo−
bound tightly to the unmodified controls when the correct dCTP was introduced in the
ternary system (Figure 4). In the unmodified 85-mer, the binding affinities of dATP,
dGTP, and dTTP to the 84-mer controls are reduced by 315-, 284-, and 89-fold,
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respectively, relative to that of dCTP (Table 2). However, nucleotide selectivity is
significantly decreased for the ternary complexes with FABP-dG adduct. The KD value
for the 85-mer TG1*G2T is only reduced by ~5-fold in dATP, dGTP, and dTTP than
that of dCTP. Similar results were obtained for the 84-mer G2* adduct, where binding
tightness is reduced by ~2-fold in dATP, dGTP, and dTTP compared with that of dCTP.
Moreover, as in the binary system, slower dissociation rates were observed for the
unmodified and G2* modified 84-mers. The KD values of dCTP, dATP, dGTP, and
dTTP in the unmodified and G2* modified 84-mers are smaller than those of the
unmodified 85-mer (5- and 13-fold smaller in dCTP and dTTP) and G1* modified 85mer TG1*G2T (4-, 13-, 10-, and 12-fold smaller in dCTP, dATP, dGTP, and dTTP,
respectively).
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Table 2. SPR binding affinities, KD (nM) of unmodified (TG1G2T) and FABP−dG
adducts (TG1[FABP]G2T and TG1G2[FABP]T) with Kf-exo− (steady-state affinity
analysis) in the binary and ternary systems. Association and dissociation rate constants,
ka and kd, in binary system are listed.
Sequence

#

Binary

KD of Ternary (nM)

ka (1/Ms)
x107

kd (1/s)

KD (nM)

dCTP

dATP

dGTP

dTTP

85-mer
TG1*G2T

15.90
(0.17)#

0.170
(0.002)

1.050
(0.050)

0.200
(0.060)

1.17
(0.04)

1.08
(0.07)

1.08
(0.08)

85-mer
control

9.59
(0.05)

0.840
(0.004)

8.740
(0.030)

0.022
(0.001)

14.90
(5.00)

11.40
(4.20)

5.14
(0.74)

84-mer
TG1G2*T

11.10
(0.07)

0.009
(0.000)

0.086
(0.001)

0.045
(0.006)

0.09
(0.00)

0.11
(0.00)

0.09
(0.01)

84-mer
control

6.33
(0.04)

0.030
(0.002)

0.480
(0.030)

0.004
(0.000)

1.39
(0.02)

1.25
(0.01)

0.39
(0.04)

standard deviation
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Figure 4. Sensorgrams of the ternary Kf-exo− complexed with (a) 85-mer control, (b)
85-mer TG1[FABP]G2T, (c) 84-mer control and (d) 84-mer TG1G2[FABP]T sequences
in the presence of dNTPs (1:1 binding fitted curves are overlaid as black lines).
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DISCUSSION
We previously conducted [23] systematic spectroscopic, thermodynamic, and chip
binding (19F-NMR, CD, DSC, and SPR) studies for the extension of 16-mer TG1*G2T
and TG1G2*T (G*=FABP) sequences. These protein free model systems mimic a
translesion synthesis of the bulky FABP lesion in two very distinctive sequencedependent conformational heterogeneities at G1 (67%B:33%S) and G2 (100%B). The
results indicate that the sequence-dependent conformational complexities appear to
persist at various elongation positions, including the ss/ds junction. The B-conformer is
a major thermodynamic stabilizer in duplex settings, whereas the S-conformer is a
destabilizer. However, the opposite is the case for adduct at the ss/ds junction. In
particular, the S-conformation promotes lesion stacking with nascent base pairs at the
replication fork. SPR results reveal that the S-conformation increases the binding
affinity with the complementary strands in the order of G1* > G2*. In the present work,
we examined the effects of these unusual sequence effects on Klenow polymerase
binding (binary and ternary) and nucleotide insertion kinetics.

Improvement on Model Hairpin Oligonucleotide Construction
We previously reported a construction of biotinylated hairpin-based template–
primer strand for DNA–polymerase SPR binding studies [27, 39-40]. The general
strategy was to ligate a biotinylated arylamine-modified 31-mer sequence with 52-mer
hairpin DNA to form an 83-mer hairpin. This was then followed by addition of a ddNTP
to the 3′-end to prevent potential primer elongation. However, the ddNTP addition step
was low yielding and the purification of ligated products was difficult. In the present
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study, we succeeded in direct ligation of a biotinylated modified 31-mer with ddNTPcontaining 53- and 54-mer hairpin DNA. This process improved the yield significantly
(from ~10% to ~ 30%), and the products were readily separated by HPLC. Also,
previously, individual dNTPs (100 μM) were mixed with varying concentrations of Kfexo– in sample buffers and injected over the surface without any dNTP in the running
buffer. This would create a complication resulting in two variables, concentrations of
dNTPs and Kf–exo– [39]. In the present work, we circumvented the complication by
adding individual dNTP in running buffer and introducing Kf–exo– directly onto the
chip surface. This system has only one variable, thus increasing the system stability and
accuracy for the translesion synthesis.

Lesion and Sequence Effects on SPR Binding Affinities and Kinetics
Tight binding of Kf–exo– with the unmodified dG control was observed when the
correct nucleotide dCTP was presented in both 85-mer and 84-mer. This result is in a
good agreement with expectation and shows high nucleotide selectivity (KD dCTP ≪ KD

dTTP

< KD dATP ~ KD dGTP). Meanwhile, a remarkably tighter binding of Kf–exo– was

found for the FABP-modified sample relative to the control: i.e., the KD of the 85-mer
G1* and 84-mer G2* interactions are 8.3 and 5.6 fold higher than the corresponding
unmodified controls, respectively. Adduct-induced tighter binding affinity with Kf–
exo– has been reported [27, 41] and may be due to the interactions between the bulky
FABP and the nearby hydrophobic amino-acid residues in the active site of the Kf-exo–.
In the ternary system, nucleotide selectivity is low. In particular, the KD of the dCTP at
the opposite G1* and G2* are only ~5- and ~2-fold tighter than the incorrect dATP,
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dGTP, and dTTP, respectively. This is a strong lesion effect. We observed that the usual
1:1 model SPR simulation did not provide a clean fit of dCTP for G1* in the ternary
system. It is possible that the present DNA adduct-Kf complex exist in multiple stages
due to the FABP-induced S/B conformational heterogeneity at G1* replication fork.
However, in most cases conformational changes in protein are much faster than SPR
time scale and thus additional studies would be necessary to confirm these possibilities.
Our HPLC-based steady-state kinetics data indicate competitive inhibition for the
S/B-conformer replication fork at G1*. In other words, the S/B conformational
heterogeneity at G1* is inhibitory to replication probably due to some unfavorable clash
of the bulky FABP lesion with the incoming dCTP in a competitive manner. The
unfavorable interactions may be caused by the competition of S-conformer with dCTP
opposite of dG. However, the exclusively B-conformeric G2* accommodates well for
the incoming dCTP, resulting in non-competitive inhibition. The equal affinity (Km)
between G2* and its unmodified dG reveals that the B-conformation in the major grove
may not interfere with the insertion of the correct dCTP. This finding might also explain
the greater KD of dCTP at G1* over G2* of the SPR results and indicates a weaker
binding affinity for G1* over G2*. Alternatively, the B-conformer may not interfere with
the Watson–Crick base pair, but it may alter the native conformations or hinder the
formation of phosphodiester bond. The S-conformer portion of G1* cannot provide a
proper Watson–Crick base pair for replication and it may need to convert back to the Bconformation to be replicated properly. Thus, the S-conformer may function as a
competitive inhibitor for replication. We observed a competitive-inhibition model for
G1* but a non-competitive-inhibition model for G2*. These types of intermediate
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interactions may be a necessary step in the DNA polymerase proofreading process as
well.
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MATERIALS AND METHODS
Model Oligonucleotide DNA sequences.
FABP-modified 16-mer templates were prepared in accordance with the published
procedures

[42]:

Two

mono-adducts

(d(5′-CTTCTG1*G2TCCTCATTC-3′))

(G*=FABP) (G1* adduct) and (d(5′-CTTCTG1G2*TCCTCATTC-3′)) (G2* adduct). 5′Biotin-labeled 31-mer oligonucleotides, 5′-phosphorylated and 3′-dideoxy-A 53-mer,
5′-phosphorylated and 3′-dideoxy-C 54-mer were purchased from IDT (Integrated DNA
Technologies Inc., Coralville, IA) in desalted form and purified by reverse-phase highperformance liquid chromatography (RP-HPLC). Kf-exo− (D355A, E357A) was
purchased from NEB Inc. (Ipswich, MA). All HPLC solvents were purchased from
Fisher Inc. (Pittsburgh, PA). The modified oligonucleotides were purified by HPLC
(Thermo Scientific, Madison, WI) on a Phenomenex Luna C18 analytical column (100
× 46 mm, 3.0 μm) (Phenomenex, Torrance, CA). For the FABP-modified biotinylated
31-mer sequence, a 0.2 mL/min flow rate was used in a 48 min linear gradient profile
(2% to 26%, v/v) acetonitrile with 100 mM TEAA buffer (pH 7.0) in mobile phase
(Figure S1a).

HPLC-based Steady-State Kinetic Analysis
The extension efficiency of Kf-exo− polymerase opposite G1* and G2* adducts was
determined by steady-state kinetic experiments as described by published procedures
[27, 43-45]. All reactions were performed using Kf-exo− (100 nM) and primers (5 µM)
in NEB buffer 2 (New England Biolabs, MA) at 22 °C. The primers (8-mer to 12-mer)
were pre-annealed with 6.75 µM FABP-modified or unmodified 16-mer templates by
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heating up to 70 °C and slowly cooling down to room temperature. Five different
concentrations of dCTP or dATP (0, 12.5, 25, 50, and 100 µM) were used to initiate
nucleotide insertion. All reactions were quenched by adding 10mM EDTA followed by
immediately denaturing at 80 °C. The initial velocity of each reaction within the steadystate range was then obtained by performing every reaction within a short time period
from 5 s to 30 s. The extended and unextended primers were separated by anionexchange HPLC with a 1.5 M ammonium acetate gradient of 40-60% in water for 6.5
min and quantified by the absorbance of UV at 260 nm. All reactions were performed
at 22 °C in triplicate, and the results were analyzed with a GraphPad Prism 5 software
by using the Lineweaver–Burk model. The inhibition curves were fitted to the equation
1/V = 1/Vmax + (KM/Vmax)/[SdCTP]. The relative insertion efficiency fins was obtained as
(kcat /KM)modified/(kcat /KM)unmodified.

SPR Measurements
FABP-modified Hairpin Template/Primer Constructs. 5′-Biotinylated 31-mer
containing dG-C8-FABP in the “-TG1G2T-” sequence context was used in SPR analysis
following the reported procedures [27, 39-40]. The two FABP-modified biotinylated
31-mer G1* and G2* adducts were separated by RP-HPLC and characterized by
MALDI-TOF MS [36]. The 84-mer and 85-mer hairpin–template–primer were prepared
by following the reported protocols [27, 39]. Briefly, two different lengths of hairpin
DNA sequences (53- and 54-mer) were phosphorylated at their 5′-ends, but their 3′-ends
were modified with ddA and ddC, respectively, to prevent further primer elongation
(Figure 2a). The biotinylated 31-mer modified G1* adduct and 54-mer hairpin were
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desalted by G-25 spin columns and annealed together by heating to 95 °C for 5 min and
cooling to room temperature. The mixture solution was ligated in a buffer containing
4,000 units of T4 ligase enzyme for 16 h at room temperature. The resulting 85-mer
oligonucleotide was purified in 15% denaturing polyacrylamide gel and extracted using
the electroelution method followed by desalting by again using G-25 spin columns. The
corresponding biotinylated 85-mer was finally purified by RP-HPLC. G2* adduct
biotinylated 84-mer and unmodified biotinylated 84- and 85-mers were also prepared
similarly. All the 84- and 85-mer oligonucleotides were identified by the 15%
denaturing polyacrylamide gel (Figure S2).

Immobilization of Streptavidin (SA) on CM5 S Chip and DNA Coating. SPR
experiments were carried out using Biacore T200 (GE Healthcare, Piscataway, NJ).
The SA via the amine coupling kit was immobilized on flow cells on the
carboxymethylated dextran-coated CM5 S chip by following the reported procedures
[27, 39]. After SA immobilization at around 2,000 RU on the flow cells, the chip
surface was washed with 50 mM NaOH for 60 s five times to reach below 20 RU.
Then, the running buffer was injected three times, and the system was equilibrated
with running buffer for 2 h. The 84- and 85-mer unmodified and modified G1* and
G2* biotinylated DNA sequences (2 nM) were injected over the flow cells (2 to 4) for
90-120 s to achieve 5-6 RU. The surface was stabilized with running buffer for 3 h
before conducting SPR binding affinity experiments.

Real-time Kinetic Analysis by SPR.
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The SPR system was first primed at least three times with running buffer and zeroconcentration injections to condition the plasmon surface. The DNA was coated on the
SA surface of flow cell 2 to 4 (cell 1 as blank reference). Surface testing, regeneration
buffer scouting, and mass transport limitation test were conducted prior to kinetic
experiments following previous reports [27, 39]. DNA coating around 4-5 RU did not
show any impact of mass transport. The steady-state affinity analysis of Kf-exo−
binding to unmodified and modified DNA was analyzed in the absence (binary) and
presence of dNTPs (ternary) by varying Kf-exo− concentrations.
For the binary system, Kf-exo− was injected without dNTPs over the DNA surface
in varying concentrations (0-25 nM) and repeated twice as described previously [27].
Briefly, the 1× HBS-P running buffer (containing 100 μg/mL bovine serum albumin
[BSA] and 5 mM MgCl2) with six different concentrations Kf-exo− (0-25 nM) was
injected for 30 s at a flow rate of 100 μL/min over the cells. Afterward, 0.05% SDS
was applied as regeneration solution at a flow rate of 100 μL/min over the surface for
30 s. The surface was stabilized with running buffer for 15 min after a regeneration
step between different concentration circles.
For the ternary system, dNTPs were injected with the HBS-P running buffer for
comparison. 1× HBS-P running buffer (100 μg/mL BSA, 5 mM MgCl2, and 100 μM
individual dNTPs) with varying concentrations of Kf-exo− was injected over the
surface. For both binary and ternary systems, sensorgrams were fitted by using a 1:1
Langmuir model, and the binding affinity constants (KD) were determined using
steady-state affinity analysis in the BIA evaluation software v 1.0 provided by the
manufacturer (GE Healthcare).
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CONCLUSIONS
In this paper, we conducted SPR and HPLC-based steady-state kinetics studies to probe
adduct-induced conformation-dependent replication block during translesion synthesis
(TLS). The FABP-modified DNA adduct adopts a mixture of B and S conformations in
the TG1*G2T (67%B:33%S), but shows exclusively B conformation in the TG1G2*T
sequence context [23]. According to the present Lineweaver–Burk enzyme inhibition
model, the S/B-conformeric mix G1* adduct exhibits a competitive-inhibition, whereas
the B-conformeric G2* adduct behaves as a non-competitive inhibitor in the nucleotide
insertion step. These results indicate that the S-conformer may not be able to
accommodate the incoming dCTP and exhibits a competitive behavior with incoming
dNTPs, thus blocking replication. By contrast, the exclusive B-conformer G2* does not
interfere with the Watson-Crick base pairing, resulting in a proper dCTP insertion. As
such, the B-conformer shows a non-competitive-inhibition behavior. The SPR binding
results implicate an adduct-induced tight binding with Kf-exo– in a binary system. In the
ternary system, nucleotide selectivity decreases when G1 and G2 are modified by FABP.
From these experiments, we observed the effect of conformational heterogeneity
induced by bulky lesion on replication block.
It has been reported that compared with other cancers, the ABP-induced mutations
are more evenly distributed along the p53 gene and the mutation hotspots occur through
the genome with the major mutation being G to T transversion [21-22]. TLS over dGC8-ABP in two different sequences (CCG*GAGGC and CCGGAG*GCC, G*=dG-C8ABP), which represent codon 248 and 249 sequences of the human p53 tumor
suppressor gene, respectively, has confirmed that codon 248 is a hot spot for adduct
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formation and G to T mutation. These results suggest that the efficiency of TLS over
dG-C8-ABP is affected by the surrounding DNA sequences of the ABP lesion,
consequently the B/S conformational heterogeneity as described here. Elucidation of
conformation-specific bypass, mutational and repair processes over the ABP adducts in
cell should clarify the molecular mechanisms underlying ABP-induced mutagenesis and
carcinogenesis.
In the present paper, we demonstrated the combination of SPR binding and HPLC
steady-state kinetics as a power tool in investigating FABP-induced conformational
heterogeneity in TLS. This approach can be applied to studying other bulky DNA
adducts.
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(a)

(b)

(c)

Figure S1. HPLC profile of FABP-modified bio-31mer TGGT template and MALDITOF characterization of peak 1 and peak 2. (a) HPLC chromatogram of a reaction
mixture of biotinylated-31-mer sequence (5'-Bio-CCTCTTCCCTCACCTCTTC
TG1G2TCCTCATTC-3') with an activated FABP (N-Acetoxy-N-(trifluoroacetyl)-4’fluoro-4-aminobiphenyl) and photodiode array UV spectra of unmodified and monoadducts. (b) and (c): MALDI-TOF mass spectra of FABP modified biotinylated-31merTGGT. (b) 3’-Exonuclease digestions of peak 1 at 0, 1, 4, 6, 7, 8 and 10min. (c) 3’Exonuclease digestions of peak 2 at 0, 1, 4, 6, 7, 8 and 10min. Insets show the theoretical
MW of the corresponding fragments that should form after 3’-exonuclease digestion.
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Figure S2. Denaturing gel (15%) profiles of 84-mer and 85-mer ligated
oligonucleotides, 31-mer, 53-mer and 54-mer non-ligated oligonucleotides.

(a)

(b)

Figure S3. dATP Insertion efficiency of (a) 8-mer to 9-mer and (b) 11-mer to 12-mer
in control, G1*G2T-FABP and G1G2*T-FABP, respectively, at 10 min (see Figure 3 for
sequences)
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Table S1. Binding net stabilization energy of unmodified and FABP-adducts with Kfexo− in binary system (1:1 binding).
Sequence

kd (1/s)

*Net stabilization Energy (kcal/mol)

85-mer control

0.84 (0.004)

0

85-mer TG1[FABP]G2T

0.17 (0.002)

0.95

84-mer control

0.03 (0.002)

0

0.009 (0.0001)

0.71

84-mer TG1G2[FABP]T

*Net stabilization energy (kcal/mol)= -RTln(kd)modified – [-RTln(kd)unmodified
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